C70741|Anti-CD20_Monoclonal_Antibody_R7159|Modify|15-OCT-07|(null)|Anti-CD20_Monoclonal_Antibody_R159
C61411|Cancer_Disease_Progression|retire|29-OCT-07|(null)|(null)
C68555|Recommended_Intake_Property|retire|29-OCT-07|(null)|(null)
C19987|Cancer_Progression|modify|29-OCT-07|(null)|(null)
C63651|L-Epicatechin|modify|29-OCT-07|(null)|(null)
C68454|Epicatechin-3-Gallate|modify|29-OCT-07|(null)|(null)
C68453|Epigallocatechin|modify|29-OCT-07|(null)|(null)
C64871|Enema_Tablet_Dosage_Form|modify|29-OCT-07|(null)|(null)
C48198|Extravasation|modify|29-OCT-07|(null)|(null)
C49059|DICOM|modify|29-OCT-07|(null)|(null)
C64355|Scientific_Control|modify|29-OCT-07|(null)|(null)
C70582|Vibration_Respone_Imaging|create|29-OCT-07|(null)|(null)
C906|Triglycerides|modify|29-OCT-07|(null)|(null)
C2867|Amnesia|modify|29-OCT-07|(null)|(null)
C48570|Percent_Unit|modify|29-OCT-07|(null)|(null)
C48527|Percent_Weight_Volume|modify|29-OCT-07|(null)|(null)
C67374|International_Unit_of_Vitamin_A|modify|29-OCT-07|(null)|(null)
C67380|International_Unit_per_Milligram|modify|29-OCT-07|(null)|(null)
C67381|International_Unit_per_Milligram_of_Alpha-Tocopherol|modify|29-OCT-07|(null)|(null)
C48579|International_Unit_of_Biological_Activity|modify|29-OCT-07|(null)|(null)
C67378|International_Unit_per_Square_Meter|modify|29-OCT-07|(null)|(null)
C67283|Intravenous_Bag_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C67382|Kilounit_per_Kilogram|modify|29-OCT-07|(null)|(null)
C1019|Bisantrene|modify|29-OCT-07|(null)|(null)
C1026|Bryostatin-1|modify|29-OCT-07|(null)|(null)
C966|Dichloromethotrexate|modify|29-OCT-07|(null)|(null)
C869|Thalicarpine|modify|29-OCT-07|(null)|(null)
C504|Floxuridine|modify|29-OCT-07|(null)|(null)
C1335|Aminothiadiazole|modify|29-OCT-07|(null)|(null)
C44415|N-Methyl-N-nitro-N-Nitrosoguanidine|modify|29-OCT-07|(null)|(null)
C404|Cycloleucine|modify|29-OCT-07|(null)|(null)
C626|Maytansine|modify|29-OCT-07|(null)|(null)
C1163|N-Methylformamide|modify|29-OCT-07|(null)|(null)
C249|Aniline_Mustard|modify|29-OCT-07|(null)|(null)
C895|Chromomycin_A3|modify|29-OCT-07|(null)|(null)
C352|Carubicin|modify|29-OCT-07|(null)|(null)
C405|Cyclophosphamide|modify|29-OCT-07|(null)|(null)
C1363|Diaziquone|modify|29-OCT-07|(null)|(null)
C427|Diazooxonorleucine|modify|29-OCT-07|(null)|(null)
C195|Mercaptopurine|modify|29-OCT-07|(null)|(null)
C1423|Perfosfamide|modify|29-OCT-07|(null)|(null)
C1389|Menogaril|modify|29-OCT-07|(null)|(null)
C425|Dianhydrogalactitol|modify|29-OCT-07|(null)|(null)
C544|Altretamine|modify|29-OCT-07|(null)|(null)
C1783|Piposulfan|modify|29-OCT-07|(null)|(null)
C877|Thioinosine|modify|29-OCT-07|(null)|(null)
C1268|Trofosfamide|modify|29-OCT-07|(null)|(null)
C491|Etoposide|modify|29-OCT-07|(null)|(null)
C1025|Bruceantin|modify|29-OCT-07|(null)|(null)
C564|Ifosfamide|modify|29-OCT-07|(null)|(null)
C935|Vindesine_Sulfate|modify|29-OCT-07|(null)|(null)
C202|Aclarubicin|modify|29-OCT-07|(null)|(null)
C563|Idoxuridine|modify|29-OCT-07|(null)|(null)
C1416|Yoshi-864|modify|29-OCT-07|(null)|(null)
C44399|Methyl_Methanesulfonate|modify|29-OCT-07|(null)|(null)
C845|Streptozocin|modify|29-OCT-07|(null)|(null)
C1258|Triazinate|modify|29-OCT-07|(null)|(null)
C412|Dactinomycin|modify|29-OCT-07|(null)|(null)
C1186|PCNU|modify|29-OCT-07|(null)|(null)
C617|Lomustine|modify|29-OCT-07|(null)|(null)
C318|Bromodeoxyuridine|modify|29-OCT-07|(null)|(null)
C1134|Indicine-N-Oxide|modify|29-OCT-07|(null)|(null)
C1314|Trimetrexate|modify|29-OCT-07|(null)|(null)
C2216|Imidazole_Mustard|modify|29-OCT-07|(null)|(null)
C505|Fluorouracil|modify|29-OCT-07|(null)|(null)
C633|Melphalan|modify|29-OCT-07|(null)|(null)
C876|Thioguanine|modify|29-OCT-07|(null)|(null)
C349|Carmustine|modify|29-OCT-07|(null)|(null)
C645|Methylnitrosourea|modify|29-OCT-07|(null)|(null)
C289|Azaserine|modify|29-OCT-07|(null)|(null)
C700|Nogalamycin|modify|29-OCT-07|(null)|(null)
C403|Ancitabine_Hydrochloride|modify|29-OCT-07|(null)|(null)
C1190|Phenesterin|modify|29-OCT-07|(null)|(null)
C661|Mitoguazone|modify|29-OCT-07|(null)|(null)
C411|Dacarbazine|modify|29-OCT-07|(null)|(null)
C1350|Beta-Thioguanine_Deoxyriboside|modify|29-OCT-07|(null)|(null)
C1136|Inosine_Dialdehyde|modify|29-OCT-07|(null)|(null)
C1049|Chlorozotocin|modify|29-OCT-07|(null)|(null)
C362|Chlorambucil|modify|29-OCT-07|(null)|(null)
C875|Thiotepa|modify|29-OCT-07|(null)|(null)
C1007|Azapicyl|modify|29-OCT-07|(null)|(null)
C63698|_6-Chloroflavone|modify|29-OCT-07|(null)|(null)
C291|_6-Azauridine|modify|29-OCT-07|(null)|(null)
C4004|Gastric_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C4005|Malignant_Childhood_Neoplasm|modify|29-OCT-07|(null)|(null)
C4014|Adult_Oligodendroglioma|modify|29-OCT-07|(null)|(null)
C9133|Adenosquamous_Lung_Carcinoma|modify|29-OCT-07|(null)|(null)
C4024|Esophageal_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C4026|Ovarian_Mucinous_Cystadenocarcinoma|modify|29-OCT-07|(null)|(null)
C4034|Recurrent_Laryngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C4043|Hypopharyngeal_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C4044|Laryngeal_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C4349|Colon_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C4450|Large_Cell_Lung_Carcinoma|modify|29-OCT-07|(null)|(null)
C4519|Cervical_Adenosquamous_Carcinoma|modify|29-OCT-07|(null)|(null)
C4627|Malignant_Central_Nervous_System_Neoplasm|modify|29-OCT-07|(null)|(null)
C35424|Richter_s_Syndrome|modify|29-OCT-07|(null)|(null)
C27134|Hematopoietic_Cell_Neoplasm|modify|29-OCT-07|(null)|(null)
C4767|Malignant_Eye_Neoplasm|modify|29-OCT-07|(null)|(null)
C4878|Lung_Carcinoma|modify|29-OCT-07|(null)|(null)
C8495|Hereditary_Retinoblastoma_RB1|modify|29-OCT-07|(null)|(null)
C8863|Nodal_Marginal_Zone_B-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C7328|Testicular_Seminoma|modify|29-OCT-07|(null)|(null)
C7359|Endometrial_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C5711|Stage_IV_Pancreatic_Cancer|modify|29-OCT-07|(null)|(null)
C6290|Endometrial_Adenosquamous_Carcinoma|modify|29-OCT-07|(null)|(null)
C6341|Testicular_Embryonal_Carcinoma|modify|29-OCT-07|(null)|(null)
C6349|Testicular_Mixed_Choriocarcinoma_and_Teratoma|modify|29-OCT-07|(null)|(null)
C6350|Testicular_Mixed_Embryonal_Carcinoma_and_Seminoma|modify|29-OCT-07|(null)|(null)
C6352|Testicular_Mixed_Embryonal_Carcinoma_and_Teratoma_with_Seminoma|modify|29-OCT-07|(null)|(null)
C6868|Stage_IV_Laryngeal_Cancer|modify|29-OCT-07|(null)|(null)
C7812|Solitary_Osseous_Plasmacytoma|modify|29-OCT-07|(null)|(null)
C7049|Adult_Astrocytic_Tumor|modify|29-OCT-07|(null)|(null)
C7114|Thymoma_Type_B|modify|29-OCT-07|(null)|(null)
C7174|Adult_Diffuse_Astrocytoma|modify|29-OCT-07|(null)|(null)
C7213|AIDS-Related_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C7320|Childhood_Chronic_Myelogenous_Leukemia|modify|29-OCT-07|(null)|(null)
C7395|Stage_I_Nasopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C7396|Stage_III_Nasopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C7397|Stage_IV_Nasopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C7713|Squamous_Cell_Carcinoma_Metastatic_to_the_Neck_with_Occult_Primary|modify|29-OCT-07|(null)|(null)
C7729|Squamous_Cell_Carcinoma_of_the_Penis|modify|29-OCT-07|(null)|(null)
C7736|Vaginal_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C7769|Stage_III_Breast_Cancer|modify|29-OCT-07|(null)|(null)
C7776|Stage_III_Anal_Canal_Cancer|modify|29-OCT-07|(null)|(null)
C7778|Stage_III_Non-Small_Cell_Lung_Cancer|modify|29-OCT-07|(null)|(null)
C7784|Recurrent_Childhood_Acute_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C7789|Recurrent_Adult_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C7803|Stage_II_Cervical_Cancer|modify|29-OCT-07|(null)|(null)
C7809|Adult_Fibrosarcoma|modify|29-OCT-07|(null)|(null)
C7813|Refractory_Plasma_Cell_Neoplasm|modify|29-OCT-07|(null)|(null)
C7814|Adult_Malignant_Peripheral_Nerve_Sheath_Tumor|modify|29-OCT-07|(null)|(null)
C7818|Stage_I_Adult_Soft_Tissue_Sarcoma|modify|29-OCT-07|(null)|(null)
C7819|Stage_II_Adult_Soft_Tissue_Sarcoma|modify|29-OCT-07|(null)|(null)
C7821|Stage_IV_Adult_Soft_Tissue_Sarcoma|modify|29-OCT-07|(null)|(null)
C7850|Stage_I_Multiple_Myeloma|modify|29-OCT-07|(null)|(null)
C7851|Stage_II_Multiple_Myeloma|modify|29-OCT-07|(null)|(null)
C7871|Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C7872|Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C7873|Adult_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C7882|Recurrent_Adult_Acute_Myeloid_Leukemia|modify|29-OCT-07|(null)|(null)
C7883|Recurrent_Adult_Acute_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C7886|Refractory_Chronic_Lymphocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C7920|Stage_II_Nasopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C7927|Liver_and_Intrahepatic_Biliary_Tract_Carcinoma|modify|29-OCT-07|(null)|(null)
C7936|Adult_Acute_Myeloid_Leukemia_in_Remission|modify|29-OCT-07|(null)|(null)
C7937|Adult_Acute_Lymphoblastic_Leukemia_in_Remission|modify|29-OCT-07|(null)|(null)
C7938|Childhood_Acute_Lymphoblastic_Leukemia_in_Remission|modify|29-OCT-07|(null)|(null)
C7947|Adult_Malignant_Mesenchymoma|modify|29-OCT-07|(null)|(null)
C7950|Invasive_Lobular_Breast_Carcinoma|modify|29-OCT-07|(null)|(null)
C7953|Childhood_Precursor_T_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C27278|L1_Adult_Acute_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C7955|Childhood_Hepatocellular_Carcinoma|modify|29-OCT-07|(null)|(null)
C7956|Adult_Hepatocellular_Carcinoma|modify|29-OCT-07|(null)|(null)
C7961|Adult_Acute_Myeloid_Leukemia_with_Maturation|modify|29-OCT-07|(null)|(null)
C7962|Adult_Acute_Myelomonocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C7963|Adult_Acute_Eosinophilic_Leukemia|modify|29-OCT-07|(null)|(null)
C7964|Adult_Acute_Basophilic_Leukemia|modify|29-OCT-07|(null)|(null)
C7965|Adult_Acute_Megakaryoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C7966|Colon_Mucinous_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C7967|Colon_Signet_Ring_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C7968|Childhood_Acute_Promyelocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C7970|Childhood_Acute_Myelomonocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C7971|Childhood_Acute_Basophilic_Leukemia|modify|29-OCT-07|(null)|(null)
C7972|Childhood_Acute_Megakaryoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C7973|Rectal_Mucinous_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C7975|Extrahepatic_Bile_Duct_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C7977|Pancreatic_Acinar_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C7978|Ovarian_Serous_Cystadenocarcinoma|modify|29-OCT-07|(null)|(null)
C7981|Vaginal_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C7986|Spindle_Cell_Uveal_Melanoma|modify|29-OCT-07|(null)|(null)
C35781|Mixed_Cell_Uveal_Melanoma|modify|29-OCT-07|(null)|(null)
C7991|Salivary_Gland_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C7992|Nasopharyngeal_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C7993|Parathyroid_Clear_Cell_Adenoma|modify|29-OCT-07|(null)|(null)
C7994|Parathyroid_Mixed_Cell_Type_Adenoma|modify|29-OCT-07|(null)|(null)
C7995|Granular_Renal_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C8000|Testicular_Yolk_Sac_Tumor|modify|29-OCT-07|(null)|(null)
C8001|Testicular_Mixed_Embryonal_Carcinoma_and_Yolk_Sack_Tumor|modify|29-OCT-07|(null)|(null)
C8002|Testicular_Mixed_Yolk_Sac_Tumor_and_Teratoma|modify|29-OCT-07|(null)|(null)
C8003|Testicular_Mixed_Yolk_Sac_Tumor_and_Teratoma_with_Seminoma|modify|29-OCT-07|(null)|(null)
C8012|Low-Grade_Salivary_Gland_Carcinoma|modify|29-OCT-07|(null)|(null)
C8013|Salivary_Gland_Acinic_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C8014|Lip_Basal_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C8015|Low-Grade_Salivary_Gland_Mucoepidermoid_Carcinoma|modify|29-OCT-07|(null)|(null)
C8018|High-Grade_Salivary_Gland_Carcinoma|modify|29-OCT-07|(null)|(null)
C8019|High-Grade_Salivary_Gland_Mucoepidermoid_Carcinoma|modify|29-OCT-07|(null)|(null)
C8021|Salivary_Gland_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C8024|Undifferentiated_Salivary_Gland_Carcinoma|modify|29-OCT-07|(null)|(null)
C8025|Malignant_Mixed_Tumor_of_the_Salivary_Gland|modify|29-OCT-07|(null)|(null)
C8026|Salivary_Gland_Adenoid_Cystic_Carcinoma|modify|29-OCT-07|(null)|(null)
C8028|Endometrial_Clear_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C8029|Progressive_Hairy_Cell_Leukemia_Initial_Treatment|modify|29-OCT-07|(null)|(null)
C8030|Refractory_Hairy_Cell_Leukemia|modify|29-OCT-07|(null)|(null)
C8038|Stage_I_Hypopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C8039|Stage_II_Hypopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C8040|Stage_III_Hypopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C8041|Stage_I_Laryngeal_Cancer|modify|29-OCT-07|(null)|(null)
C8042|Stage_II_Laryngeal_Cancer|modify|29-OCT-07|(null)|(null)
C8043|Stage_III_Laryngeal_Cancer|modify|29-OCT-07|(null)|(null)
C8048|Stage_I_Oropharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C8049|Stage_II_Oropharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C8050|Stage_III_Oropharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C8055|Stage_II_Pediatric_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8056|Stage_I_Pediatric_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8057|Stage_III_Pediatric_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8058|Stage_IV_Pediatric_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8059|Recurrent_Childhood_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8061|Childhood_Lymphocyte_Depleted_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8062|Childhood_Nodular_Sclerosis_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8063|Childhood_Mixed_Cellularity_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8070|Stage_I_Small_Lymphocytic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8071|Stage_I_Grade_1_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8072|Stage_I_Grade_2_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8073|Stage_I_Grade_3_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8075|Stage_I_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8076|Stage_I_Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8077|Stage_I_Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8078|Stage_I_Adult_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8079|Stage_I_Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8080|Stage_I_Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8097|Childhood_Malignant_Mesenchymoma|modify|29-OCT-07|(null)|(null)
C8098|Recurrent_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8099|Squamous_Cell_Carcinoma_of_Unknown_Primary|modify|29-OCT-07|(null)|(null)
C8100|Undifferentiated_Carcinoma_of_Unknown_Primary|modify|29-OCT-07|(null)|(null)
C8101|Adult_Solid_Neoplasm|modify|29-OCT-07|(null)|(null)
C8102|Stage_I_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8103|Stage_II_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8104|Stage_III_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8105|Stage_IV_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C39990|Polyembryoma_of_the_Ovary|modify|29-OCT-07|(null)|(null)
C8110|Ovarian_Teratoma|modify|29-OCT-07|(null)|(null)
C70584|MITF_Gene|create|29-OCT-07|(null)|(null)
C70585|MITF_wt_Allele|create|29-OCT-07|(null)|(null)
C70586|Microphthalmia-Associated_Transcription_Factor|create|29-OCT-07|(null)|(null)
C64916|All|modify|29-OCT-07|(null)|(null)
C50158|Scanner_Device_Component|modify|29-OCT-07|(null)|(null)
C47876|Resolution_Property|modify|29-OCT-07|(null)|(null)
C8112|Mature_Ovarian_Teratoma|modify|29-OCT-07|(null)|(null)
C8113|Ovarian_Monodermal_and_Highly_Specialized_Teratoma|modify|29-OCT-07|(null)|(null)
C8114|Ovarian_Mixed_Germ_Cell_Tumor|modify|29-OCT-07|(null)|(null)
C8115|Stage_II_Small_Lymphocytic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8116|Stage_II_Grade_1_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8117|Stage_II_Grade_2_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8119|Stage_II_Grade_3_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8120|Stage_II_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8121|Stage_II_Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8122|Stage_II_Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8124|Stage_II_Adult_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8125|Stage_II_Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8126|Stage_II_Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8128|Stage_III_Small_Lymphocytic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8129|Stage_III_Grade_1_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8130|Stage_III_Grade_2_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8132|Stage_III_Grade_3_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8133|Stage_III_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8134|Stage_III_Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8135|Stage_III_Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8137|Stage_III_Adult_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8138|Stage_III_Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8139|Stage_III_Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8141|Stage_IV_Small_Lymphocytic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8142|Stage_IV_Grade_1_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8143|Stage_IV_Grade_2_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8145|Stage_IV_Grade_3_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8146|Stage_IV_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8147|Stage_IV_Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8148|Stage_IV_Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8150|Stage_IV_Adult_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8151|Stage_IV_Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8152|Stage_IV_Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C70587|Hydrated_Sodium_Calcium_Aluminosilicate|create|29-OCT-07|(null)|(null)
C8155|Recurrent_Grade_1_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8156|Recurrent_Grade_2_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8158|Recurrent_Grade_3_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8160|Recurrent_Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8161|Recurrent_Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8163|Recurrent_Adult_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8164|Recurrent_Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8159|Recurrent_Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8174|Oral_Cavity_Verrucous_Carcinoma|modify|29-OCT-07|(null)|(null)
C8177|Oral_Cavity_Mucoepidermoid_Carcinoma|modify|29-OCT-07|(null)|(null)
C70588|Recurrent_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|create|29-OCT-07|(null)|(null)
C3464|Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8471|Stage_II_Contiguous_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C9197|Stage_II_Non-Contiguous_Adult_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8996|Malignant_Lymphoma_Follicular_Large_Cleaved_Cell_Type|modify|29-OCT-07|(null)|(null)
C8995|Malignant_Lymphoma_Follicular_Large_Noncleaved_Cell_Type|modify|29-OCT-07|(null)|(null)
C8475|Stage_II_Contiguous_Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8480|Stage_II_Non-Contiguous_Adult_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8296|AIDS-Related_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C70589|Abundance|create|29-OCT-07|(null)|(null)
C3210|Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C3463|Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8474|Stage_II_Contiguous_Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C45676|Multiplicity|modify|29-OCT-07|(null)|(null)
C9199|Stage_II_Non-Contiguous_Adult_Diffuse_Mixed_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C5314|Primary_Low-Grade_B-Cell_Dural_Lymphoma|modify|29-OCT-07|(null)|(null)
C27361|Philadelphia_Chromosome_Negative_BCR-ABL_Negative_Chronic_Myelogenous_Leukemia|modify|29-OCT-07|(null)|(null)
C26919|Lymphosarcoma|modify|29-OCT-07|(null)|(null)
C8310|Childhood_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C9076|Childhood_Diffuse_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8309|Recurrent_Childhood_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8305|Stage_I_Childhood_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8306|Stage_II_Childhood_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8307|Stage_III_Childhood_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8308|Stage_IV_Childhood_Large_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C26732|Coronary_Disease|modify|29-OCT-07|(null)|(null)
C8179|Oral_Cavity_Adenoid_Cystic_Carcinoma|modify|29-OCT-07|(null)|(null)
C8181|Oropharyngeal_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C8188|Laryngeal_Verrucous_Carcinoma|modify|29-OCT-07|(null)|(null)
C8247|Stage_I_Adult_T-Cell_Lymphoma_Leukemia|modify|29-OCT-07|(null)|(null)
C8248|Stage_II_Adult_T-Cell_Lymphoma_Leukemia|modify|29-OCT-07|(null)|(null)
C8249|Stage_III_Adult_T-Cell_Lymphoma_Leukemia|modify|29-OCT-07|(null)|(null)
C8250|Stage_IV_Adult_T-Cell_Lymphoma_Leukemia|modify|29-OCT-07|(null)|(null)
C70590|Subtraction|create|29-OCT-07|(null)|(null)
C25765|Secondary_Acute_Myeloid_Leukemia|modify|29-OCT-07|(null)|(null)
C8253|de_novo_Myelodysplastic_Syndrome|modify|29-OCT-07|(null)|(null)
C8265|Adult_Primary_Cholangiocarcinoma|modify|29-OCT-07|(null)|(null)
C27280|Secondary_Myelodysplastic_Syndrome|modify|29-OCT-07|(null)|(null)
C8273|Adult_Pineal_Parenchymal_Cell_Neoplasm|modify|29-OCT-07|(null)|(null)
C8275|Adult_Anaplastic_Malignant_Meningioma|modify|29-OCT-07|(null)|(null)
C8284|AIDS-Related_Primary_Central_Nervous_System_Lymphoma|modify|29-OCT-07|(null)|(null)
C8285|AIDS_Related_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8286|ENV_Gene|modify|29-OCT-07|(null)|(null)
C8293|Adult_Papillary_Meningioma|modify|29-OCT-07|(null)|(null)
C38938|Grade_III_Meningioma|modify|29-OCT-07|(null)|(null)
C8294|Pancreatic_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C8297|AIDS-Related_Diffuse_Small_Cleaved_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8298|AIDS-Related_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8303|Adult_Acute_Myeloid_Leukemia_Minimally_Differentiated|modify|29-OCT-07|(null)|(null)
C8304|Childhood_Acute_Myeloid_Leukemia_Minimally_Differentiated|modify|29-OCT-07|(null)|(null)
C8335|Low_Grade_Squamous_Intraepithelial_Neoplasia|modify|29-OCT-07|(null)|(null)
C8336|High-Grade_Squamous_Intraepithelial_Neoplasia|modify|29-OCT-07|(null)|(null)
C9111|Meningeal_Chronic_Myelogenous_Leukemia|modify|29-OCT-07|(null)|(null)
C8464|Stage_I_Indolent_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8465|Stage_I_Mantle_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8466|Stage_II_Contiguous_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8467|Stage_II_Contiguous_Adult_Indolent_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8468|Stage_II_Grade_1_Contiguous_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8469|Stage_II_Grade_2_Contiguous_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8470|Stage_II_Grade_3_Contiguous_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C8472|Stage_II_Contiguous_Adult_Aggressive_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8473|Stage_II_Contiguous_Mantle_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C67385|Kilounit_per_Liter|modify|29-OCT-07|(null)|(null)
C8476|Stage_II_Contiguous_Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8477|Stage_II_Non-Contiguous_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8478|Stage_II_Non-Contiguous_Adult_Indolent_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8479|Stage_II_Non-Contiguous_Aggressive_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8481|Stage_II_Non-Contiguous_Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8482|Stage_III_Indolent_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8484|Stage_III_Aggressive_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8485|Stage_IV_Indolent_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8486|Stage_IV_Mantle_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8487|Stage_IV_Aggressive_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8489|Recurrent_Mantle_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C8490|Recurrent_Aggressive_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8491|Indolent_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8492|Aggressive_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C8498|Hereditary_Melanoma_1_and_2_CDKN2_CDK4|modify|29-OCT-07|(null)|(null)
C8533|Stage_IV_Hypopharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C8564|Stage_II_Adult_Contiguous_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C35741|Non-Neoplastic_Heart_Disorder|modify|29-OCT-07|(null)|(null)
C8565|Stage_II_Adult_Non-Contiguous_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C8960|Familial_Renal_Oncocytoma|modify|29-OCT-07|(null)|(null)
C9032|Stage_I_Adult_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9033|Stage_II_Adult_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9034|Stage_III_Adult_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9035|Stage_IV_Adult_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C7852|Stage_III_Multiple_Myeloma|modify|29-OCT-07|(null)|(null)
C70591|Gel_Warping_Algorithm|create|29-OCT-07|(null)|(null)
C9056|Stage_I_Childhood_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C9057|Stage_II_Childhood_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C9058|Stage_III_Childhood_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C9059|Stage_IV_Childhood_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C9060|Recurrent_Childhood_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C9062|Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9068|Recurrent_Childhood_Acute_Myeloid_Leukemia|modify|29-OCT-07|(null)|(null)
C9070|Relapsed_Chronic_Myelogenous_Leukemia|modify|29-OCT-07|(null)|(null)
C9079|Childhood_Immunoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C9092|Adult_Ependymoma|modify|29-OCT-07|(null)|(null)
C9095|Childhood_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9107|Childhood_Solid_Neoplasm|modify|29-OCT-07|(null)|(null)
C9115|Childhood_Acute_Myeloid_Leukemia_in_Remission|modify|29-OCT-07|(null)|(null)
C9120|Pancreatic_Ductal_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C7319|Adult_Acute_Monoblastic_Leukemia_and_Acute_Monocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C4509|Undifferentiated_Ovarian_Carcinoma|modify|29-OCT-07|(null)|(null)
C40090|Malignant_Ovarian_Mixed_Epithelial_Tumor|modify|29-OCT-07|(null)|(null)
C9163|Childhood_Acute_Differentiated_Monocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C9297|Malignant_Urinary_Tract_Neoplasm|modify|29-OCT-07|(null)|(null)
C9124|Childhood_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C7942|Adult_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9125|Adult_Lymphocyte_Depleted_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9126|Adult_Nodular_Sclerosis_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9127|Adult_Mixed_Cellularity_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9128|Philadelphia_Chromosome_Positive_Chronic_Myelogenous_Leukemia|modify|29-OCT-07|(null)|(null)
C9129|Philadelphia_Chromosome_Negative_Chronic_Myelogenous_Leukemia|modify|29-OCT-07|(null)|(null)
C9131|Mucinous_Breast_Carcinoma|modify|29-OCT-07|(null)|(null)
C9135|Tubular_Breast_Carcinoma|modify|29-OCT-07|(null)|(null)
C9136|Invasive_Lobular_Breast_Carcinoma_with_Predominant_In_Situ_Component|modify|29-OCT-07|(null)|(null)
C9140|Childhood_Precursor_B_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C9141|Non-T_Non-B_cALLa_Positive_Childhood_Acute_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C9142|Adult_Precursor_T_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C9143|Adult_Precursor_B_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C9144|Non-T_Non-B_cALLa_Positive_Adult_Acute_Lymphoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C67520|Mixed_Type_Osteosarcoma|modify|29-OCT-07|(null)|(null)
C2232|MUC-1_KLH_Vaccine|modify|29-OCT-07|(null)|(null)
C9154|Adult_Acute_Myeloid_Leukemia|modify|29-OCT-07|(null)|(null)
C9155|Adult_Acute_Promyelocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C9156|Adult_Acute_Poorly_Differentiated_Monoblastic_Leukemia|modify|29-OCT-07|(null)|(null)
C48569|Unit_of_Mass_Flow_Rate|modify|29-OCT-07|(null)|(null)
C67526|Gastric_Mixed_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C7100|Undifferentiated_Colon_Carcinoma|modify|29-OCT-07|(null)|(null)
C9162|Childhood_Acute_Monoblastic_Leukemia_without_Differentiation|modify|29-OCT-07|(null)|(null)
C67399|Milligram_per_24_Hours|modify|29-OCT-07|(null)|(null)
C67305|Microgram_per_Deciliter|modify|29-OCT-07|(null)|(null)
C66969|Milligram_per_Hour|modify|29-OCT-07|(null)|(null)
C67393|Microgram_per_24_Hours|modify|29-OCT-07|(null)|(null)
C67394|Microgram_per_Hour|modify|29-OCT-07|(null)|(null)
C67372|Gram_per_24_Hours|modify|29-OCT-07|(null)|(null)
C67306|Microgram_per_Liter|modify|29-OCT-07|(null)|(null)
C9164|Childhood_Acute_Erythroid_Leukemia|modify|29-OCT-07|(null)|(null)
C9165|Childhood_Acute_Eosinophilic_Leukemia|modify|29-OCT-07|(null)|(null)
C61571|Lyso-Thermosensitive_Liposome_Doxorubicin|modify|29-OCT-07|(null)|(null)
C9166|Gallbladder_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C9167|Undifferentiated_Gallbladder_Carcinoma|modify|29-OCT-07|(null)|(null)
C48511|Millicurie|modify|29-OCT-07|(null)|(null)
C9168|Rectal_Signet_Ring_Cell_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C9169|Gallbladder_Adenocarcinoma_with_Squamous_Metaplasia|modify|29-OCT-07|(null)|(null)
C7974|Undifferentiated_Rectal_Carcinoma|modify|29-OCT-07|(null)|(null)
C9170|Gallbladder_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C4883|Malignant_Muscle_Neoplasm|modify|29-OCT-07|(null)|(null)
C25209|Measure|modify|29-OCT-07|(null)|(null)
C8483|Stage_III_Mantle_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C67471|Milliequivalent_per_24_Hours|modify|29-OCT-07|(null)|(null)
C67472|Milliequivalent_per_Hour|modify|29-OCT-07|(null)|(null)
C26449|Monoclonal_Antibody_ACA125_Anti-Idiotype_Vaccine|modify|29-OCT-07|(null)|(null)
C67395|Unit_of_Amount_of_Substance_Rate|modify|29-OCT-07|(null)|(null)
C67475|Milliequivalent_per_Kilogram|modify|29-OCT-07|(null)|(null)
C67307|Low_Power_Field|modify|29-OCT-07|(null)|(null)
C64541|Sapacitabine|modify|29-OCT-07|(null)|(null)
C62178|L-Gossypol|modify|29-OCT-07|(null)|(null)
C40036|Borderline_Ovarian_Mucinous_Tumor|modify|29-OCT-07|(null)|(null)
C7987|Spindle_Cell_Type_A_Uveal_Melanoma|modify|29-OCT-07|(null)|(null)
C7988|Spindle_Cell_Type_B_Uveal_Melanoma|modify|29-OCT-07|(null)|(null)
C35780|Epitheliod_Cell_Uveal_Melanoma|modify|29-OCT-07|(null)|(null)
C7990|Necrotic_Uveal_Melanoma|modify|29-OCT-07|(null)|(null)
C9172|Mixed_Embryonal_Carcinoma_and_Yolk_Sac_Neoplasm_with_Seminoma_of_the_Testis|modify|29-OCT-07|(null)|(null)
C67548|Testicular_Mixed_Choriocarcinoma_and_Yolk_Sac_Tumor|modify|29-OCT-07|(null)|(null)
C9173|Testicular_Mixed_Choriocarcinoma_and_Seminoma|modify|29-OCT-07|(null)|(null)
C67460|Pancreatic_Delta_Cell_Adenoma|modify|29-OCT-07|(null)|(null)
C67140|Associate_Degree_Academic|modify|29-OCT-07|(null)|(null)
C27838|Uterine_Serous_Carcinoma|modify|29-OCT-07|(null)|(null)
C67554|Stage_I_Nasal_Cavity_and_Paranasal_Sinus_Cancer|modify|29-OCT-07|(null)|(null)
C70555|Bachelor_Degree_Completion|modify|29-OCT-07|(null)|(null)
C67555|Stage_II_Nasal_Cavity_and_Paranasal_Sinus_Cancer|modify|29-OCT-07|(null)|(null)
C70557|Doctorate_Degree_Completion|modify|29-OCT-07|(null)|(null)
C67136|High_School_Graduate|modify|29-OCT-07|(null)|(null)
C67122|Never_Attended|modify|29-OCT-07|(null)|(null)
C67556|Stage_III_Nasal_Cavity_and_Paranasal_Sinus_Cancer|modify|29-OCT-07|(null)|(null)
C6755|Pineal_Region_Immature_Teratoma|modify|29-OCT-07|(null)|(null)
C67557|Stage_IV_Nasal_Cavity_and_Paranasal_Sinus_Cancer|modify|29-OCT-07|(null)|(null)
C67141|Vocational_Degree|modify|29-OCT-07|(null)|(null)
C67558|Recurrent_Nasal_Cavity_and_Paranasal_Sinus_Cancer|modify|29-OCT-07|(null)|(null)
C8060|Childhood_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C27293|Extraosseous_Ewing_s_Sarcoma_Peripheral_Primitive_Neuroectodermal_Tumor|modify|29-OCT-07|(null)|(null)
C8094|Childhood_Malignant_Peripheral_Nerve_Sheath_Tumor|modify|29-OCT-07|(null)|(null)
C4039|Adenocarcinoma_of_Unknown_Primary|modify|29-OCT-07|(null)|(null)
C68610|Oropharyngeal_Undifferentiated_Carcinoma|modify|29-OCT-07|(null)|(null)
C68611|Nasal_Cavity_and_Paranasal_Sinus_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C6871|Inverted_Schneiderian_Papilloma|modify|29-OCT-07|(null)|(null)
C8196|Nasal_Cavity_Lethal_Midline_Granuloma|modify|29-OCT-07|(null)|(null)
C36077|Hilar_Cholangiocarcinoma|modify|29-OCT-07|(null)|(null)
C9185|Stage_I_Childhood_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9186|Stage_II_Childhood_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9187|Stage_III_Childhood_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9188|Stage_IV_Childhood_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9189|Recurrent_Childhood_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9192|Ovarian_Malignant_Mixed_Mesodermal_Mullerian_Tumor|modify|29-OCT-07|(null)|(null)
C9193|Stage_II_Contiguous_Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9194|Stage_II_Grade_1_Non-Contiguous_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C9195|Stage_II_Grade_2_Non-Contiguous_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C9196|Stage_II_Grade_3_Non-Contiguous_Follicular_Lymphoma|modify|29-OCT-07|(null)|(null)
C9198|Stage_II_Non-Contiguous_Mantle_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C9200|Stage_II_Non-Contiguous_Adult_Burkitt_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9202|Stage_II_Mantle_Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C9204|Stage_I_Cervical_Cancer|modify|29-OCT-07|(null)|(null)
C9206|Stage_IV_Cervical_Cancer|modify|29-OCT-07|(null)|(null)
C9218|Stage_IV_Oropharyngeal_Carcinoma|modify|29-OCT-07|(null)|(null)
C68627|Childhood_Extracranial_Germ_Cell_Tumor|modify|29-OCT-07|(null)|(null)
C68626|Childhood_Teratoma|modify|29-OCT-07|(null)|(null)
C68628|Childhood_Malignant_Testicular_Germ_Cell_Tumor|modify|29-OCT-07|(null)|(null)
C68629|Childhood_Malignant_Ovarian_Germ_Cell_Tumor|modify|29-OCT-07|(null)|(null)
C68632|Childhood_Extragonadal_Malignant_Germ_Cell_Tumor|modify|29-OCT-07|(null)|(null)
C9221|Recurrent_Childhood_Malignant_Germ_Cell_Neoplasm|modify|29-OCT-07|(null)|(null)
C9222|Hereditary_Renal_Papillary_Carcinoma|modify|29-OCT-07|(null)|(null)
C9234|Childhood_Spinal_Cord_Neoplasm|modify|29-OCT-07|(null)|(null)
C68634|Childhood_Atypical_Teratoid_Rhabdoid_Tumor|modify|29-OCT-07|(null)|(null)
C67214|Peripheral_Primitive_Neuroectodermal_Tumor_of_the_Kidney|modify|29-OCT-07|(null)|(null)
C68635|Well-Differentiated_Adrenal_Cortex_Carcinoma|modify|29-OCT-07|(null)|(null)
C8033|Stage_I_Lip_and_Oral_Cavity_Cancer|modify|29-OCT-07|(null)|(null)
C8034|Stage_II_Lip_and_Oral_Cavity_Cancer|modify|29-OCT-07|(null)|(null)
C8035|Stage_III_Lip_and_Oral_Cavity_Cancer|modify|29-OCT-07|(null)|(null)
C9252|Stage_I_Aggressive_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C39851|Bladder_Urothelial_Carcinoma|modify|29-OCT-07|(null)|(null)
C9110|Blast_Phase_Chronic_Myelogenous_Leukemia|modify|29-OCT-07|(null)|(null)
C9279|AIDS-Related_Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C9292|Solid_Neoplasm|modify|29-OCT-07|(null)|(null)
C9299|Acute_Undifferentiated_Leukemia|modify|29-OCT-07|(null)|(null)
C9361|Adult_Lymphoblastic_Lymphoma|modify|29-OCT-07|(null)|(null)
C9380|Adult_Acute_Myeloid_Leukemia_without_Maturation|modify|29-OCT-07|(null)|(null)
C9381|Childhood_Acute_Myeloid_Leukemia_with_Maturation|modify|29-OCT-07|(null)|(null)
C6351|Testicular_Mixed_Embryonal_Carcinoma_and_Teratoma|modify|29-OCT-07|(null)|(null)
C7528|Angioimmunoblastic_T-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C27702|Previously_Treated_Myelodysplastic_Syndrome|modify|29-OCT-07|(null)|(null)
C27780|Myelodysplastic_Myeloproliferative_Disease_Unclassifiable|modify|29-OCT-07|(null)|(null)
C27855|Multicentric_Angiofollicular_Lymphoid_Hyperplasia|modify|29-OCT-07|(null)|(null)
C45722|Combined_Thymic_Epithelial_Neoplasm|modify|29-OCT-07|(null)|(null)
C68644|Anaplastic_Adrenal_Cortex_Carcinoma|modify|29-OCT-07|(null)|(null)
C9153|Adult_Acute_Erythroid_Leukemia|modify|29-OCT-07|(null)|(null)
C67134|_12th_Grade|modify|29-OCT-07|(null)|(null)
C12421|Oral_Cavity|modify|29-OCT-07|(null)|(null)
C12404|Ovary|modify|29-OCT-07|(null)|(null)
C36263|Metastatic_Malignant_Neoplasm|modify|29-OCT-07|(null)|(null)
C4025|Esophageal_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C4052|Vulvar_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C4515|Ovarian_Choriocarcinoma|modify|29-OCT-07|(null)|(null)
C8108|Ovarian_Embryonal_Carcinoma|modify|29-OCT-07|(null)|(null)
C4563|Chronic_Eosinophilic_Leukemia|modify|29-OCT-07|(null)|(null)
C45655|Sarcomatoid_Mesothelioma|modify|29-OCT-07|(null)|(null)
C7979|Ovarian_Endometrioid_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C8111|Immature_Ovarian_Teratoma|modify|29-OCT-07|(null)|(null)
C8106|Ovarian_Dysgerminoma|modify|29-OCT-07|(null)|(null)
C8107|Ovarian_Yolk_Sac_Tumor|modify|29-OCT-07|(null)|(null)
C8011|Thyroid_Stimulating_Hormone_Secreting_Pituitary_Gland_Adenoma|modify|29-OCT-07|(null)|(null)
C4027|Vulvar_Paget_s_Disease|modify|29-OCT-07|(null)|(null)
C8022|Poorly_Differentiated_Salivary_Gland_Carcinoma|modify|29-OCT-07|(null)|(null)
C38936|Grade_I_Meningioma|modify|29-OCT-07|(null)|(null)
C38937|Grade_II_Meningioma|modify|29-OCT-07|(null)|(null)
C42690|Lip_and_Oral_Cavity_Squamous_Cell_Carcinoma|modify|29-OCT-07|(null)|(null)
C42700|Uterine_Carcinosarcoma|modify|29-OCT-07|(null)|(null)
C9383|Rectal_Adenocarcinoma|modify|29-OCT-07|(null)|(null)
C68688|Stage_II_Indolent_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C68678|Stage_I_Marginal_Zone_B-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C68679|Stage_II_Marginal_Zone_B-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C68682|Stage_III_Marginal_Zone_B-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C68683|Stage_IV_Marginal_Zone_B-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C70592|Well|create|29-OCT-07|(null)|(null)
C68684|Recurrent_Marginal_Zone_B-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C68686|Stage_II_Aggressive_Adult_Non-Hodgkin_s_Lymphoma|modify|29-OCT-07|(null)|(null)
C68703|Adult_Supratentorial_Primitive_Neuroectodermal_Tumor|modify|29-OCT-07|(null)|(null)
C68702|Adult_Giant_Cell_Glioblastoma|modify|29-OCT-07|(null)|(null)
C68701|Adult_Gliosarcoma|modify|29-OCT-07|(null)|(null)
C68699|Adult_Acute_Myeloid_Leukemia_with_t_8_21_q22_q22_AML1_CBFa_ETO|modify|29-OCT-07|(null)|(null)
C68698|Adult_Acute_Myeloid_Leukemia_with_t_16_16_p13_q22|modify|29-OCT-07|(null)|(null)
C68697|Adult_Acute_Myeloid_Leukemia_with_inv_16_p13_q22|modify|29-OCT-07|(null)|(null)
C64657|Dilute|modify|29-OCT-07|(null)|(null)
C68696|Adult_Acute_Myeloid_Leukemia_with_11q23_MLL_Abnormalities|modify|29-OCT-07|(null)|(null)
C68695|Adult_Acute_Promyelocytic_Leukemia_with_t_15_17_q22_q12_PML_RARa|modify|29-OCT-07|(null)|(null)
C68694|Adult_Erythroleukemia|modify|29-OCT-07|(null)|(null)
C68693|Adult_Pure_Erythroid_Leukemia|modify|29-OCT-07|(null)|(null)
C67455|Pancreatic_Alpha_Cell_Adenoma|modify|29-OCT-07|(null)|(null)
C68690|Adult_Ependymal_Tumor|modify|29-OCT-07|(null)|(null)
C68691|Adult_Oligodendroglial_Tumor|modify|29-OCT-07|(null)|(null)
C64911|Add|modify|29-OCT-07|(null)|(null)
C9158|Childhood_Acute_Myeloid_Leukemia_without_Maturation|modify|29-OCT-07|(null)|(null)
C8263|Adult_Acute_Differentiated_Monocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C70594|Fluorine_18_Ethylcholine|create|29-OCT-07|(null)|(null)
C7940|Childhood_Acute_Monoblastic_Leukemia_and_Acute_Monocytic_Leukemia|modify|29-OCT-07|(null)|(null)
C67237|Phosphaturic_Mesenchymal_Tumor|modify|29-OCT-07|(null)|(null)
C70595|Edit|create|29-OCT-07|(null)|(null)
C4890|Malignant_Gastrointestinal_Neoplasm|modify|29-OCT-07|(null)|(null)
C2907|Brain_Neoplasm|modify|29-OCT-07|(null)|(null)
C9118|Sarcoma_of_the_Soft_Tissue_and_Bone|modify|29-OCT-07|(null)|(null)
C68692|Childhood_Nasal_Type_Extranodal_NK_T-Cell_Lymphoma|modify|29-OCT-07|(null)|(null)
C70596|Initial_Seed|create|29-OCT-07|(null)|(null)
C64220|Random_Seed|modify|29-OCT-07|(null)|(null)
C70597|Ceftobiprole_Medocaril|create|29-OCT-07|(null)|(null)
C65306|Ceftobiprole|modify|29-OCT-07|(null)|(null)
C70598|Broad-Spectrum_Human_Papillomavirus_Vaccine_V505|create|29-OCT-07|(null)|(null)
C61087|Quadrivalent_Human_Papillomavirus_Recombinant_Vaccine|modify|29-OCT-07|(null)|(null)
C45995|Absorption|modify|29-OCT-07|(null)|(null)
C48528|Percent_Weight_Weight|modify|29-OCT-07|(null)|(null)
C70434|Home_School|modify|29-OCT-07|(null)|(null)
C67137|Some_College|modify|29-OCT-07|(null)|(null)
C48571|Percent_Volume_per_Volume|modify|29-OCT-07|(null)|(null)
C1580|Anti-DNA_Antibody|modify|29-OCT-07|(null)|(null)
C70599|Negative_Selection|create|29-OCT-07|(null)|(null)
C70600|Tumor_Purging|create|29-OCT-07|(null)|(null)
C51992|Bone_Marrow_Purging|modify|29-OCT-07|(null)|(null)
C70601|Cellular_Therapy|create|29-OCT-07|(null)|(null)
C15545|Leukocyte_Therapy|modify|29-OCT-07|(null)|(null)
C15412|Lymphokine-Activated_Killer_Cell_Therapy|modify|29-OCT-07|(null)|(null)
C67400|Milligram_per_Inhalation|modify|29-OCT-07|(null)|(null)
C70602|Ph_Negative_BCR_Positive|create|29-OCT-07|(null)|(null)
C64572|Gram_per_Cubic_Meter|modify|29-OCT-07|(null)|(null)
C36715|BCR-ABL_Fusion_Protein_Expression|modify|29-OCT-07|(null)|(null)
C70603|Continued_Complete_Response|create|29-OCT-07|(null)|(null)
C70604|Primary_Refractory_Les_than_Partial_Response_PR_to_Initial_Therapy_Primary_Induction_Failure_Resistant_PIF_Res|create|29-OCT-07|(null)|(null)
C70605|Multiple_Myeloma-Light_Chain_Only|create|29-OCT-07|(null)|(null)
C70606|Multiple_Myeloma-IgA|create|29-OCT-07|(null)|(null)
C70607|Multiple_Myeloma-IgD|create|29-OCT-07|(null)|(null)
C70608|Multiple_Myeloma-IgE|create|29-OCT-07|(null)|(null)
C70609|Multiple_Myeloma-IgG|create|29-OCT-07|(null)|(null)
C70610|Multiple_Myeloma-IgM_not_Waldenstrom_Macroglobulinemia|create|29-OCT-07|(null)|(null)
C4734|Non-Secretory_Myeloma|modify|29-OCT-07|(null)|(null)
C70611|Complement_Hemolytic_Activity_Assay|create|29-OCT-07|(null)|(null)
C17612|Central_Venous_Access_Catheter|modify|29-OCT-07|(null)|(null)
C70612|Tolerance_Induction_Pre_Solid_Organ_Transplant|create|29-OCT-07|(null)|(null)
C70548|Acquired_Pure_Red_Cell_Aplasia|modify|29-OCT-07|(null)|(null)
C61231|Aplastic_Anemia_due_to_Hepatitis|modify|29-OCT-07|(null)|(null)
C70613|Drug_Toxin-Induced_Aplastic_Anemia|create|29-OCT-07|(null)|(null)
C61229|Severe_Aplastic_Anemia|modify|29-OCT-07|(null)|(null)
C32888|Jaw_Joint|modify|29-OCT-07|(null)|(null)
C42576|Kilogram_per_Cubic_Meter|modify|29-OCT-07|(null)|(null)
C67403|Milligram_per_Milliliter_per_Minute|modify|29-OCT-07|(null)|(null)
C70614|HLA-DQB1_Gene|create|29-OCT-07|(null)|(null)
C9294|Histiocytic_and_Dendritic_Cell_Neoplasms|modify|29-OCT-07|(null)|(null)
C67404|Milligram_per_Week|modify|29-OCT-07|(null)|(null)
C48507|Microcurie|modify|29-OCT-07|(null)|(null)
C61244|DC40_Ligant_Deficiency|modify|29-OCT-07|(null)|(null)
C70615|HLA-DQB1_wt_Allele|create|29-OCT-07|(null)|(null)
C16723|Immunologic_Techniques|modify|29-OCT-07|(null)|(null)
C70616|HLA_Class_II_Histocompatibility_Antigen_DQ1_Beta_Chain|create|29-OCT-07|(null)|(null)
C70617|Total_Complement_Assay|create|29-OCT-07|(null)|(null)
C70618|Complement_Component-4|create|29-OCT-07|(null)|(null)
C70619|Anticardiolipin_IgM_Antibody|create|29-OCT-07|(null)|(null)
C70620|Lupus_Anticoagulant_Antibody|create|29-OCT-07|(null)|(null)
C67406|Micromole_per_24_Hours|modify|29-OCT-07|(null)|(null)
C67420|Millimole_per_24_Hours|modify|29-OCT-07|(null)|(null)
C67408|Microunit_per_Milliliter|modify|29-OCT-07|(null)|(null)
C70621|CD34_Selection|create|29-OCT-07|(null)|(null)
C70622|Primary_Induction_Failure|create|29-OCT-07|(null)|(null)
C67335|Million_International_Units|modify|29-OCT-07|(null)|(null)
C70623|Ph_Unknown_BCR_Positive|create|29-OCT-07|(null)|(null)
C70624|Ph_Positive_BCR_Unknown|create|29-OCT-07|(null)|(null)
C48474|Bag_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48477|Bottle_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C64769|Diphtheria_Toxin_388_Interleukin-3_Fusion_Protein|modify|29-OCT-07|(null)|(null)
C48478|Box_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48480|Capsule_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C70625|Erastin_Analogue_PRLX93936|create|29-OCT-07|(null)|(null)
C48481|Cartridge_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48484|Container_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48491|Drop_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48494|Fluid_Ounce|modify|29-OCT-07|(null)|(null)
C64775|Carcinoembryonic_Antigen-Expressing_Measles_Virus|modify|29-OCT-07|(null)|(null)
C48155|Gram|modify|29-OCT-07|(null)|(null)
C62275|Inhaler_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48504|Kit_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48505|Liter|modify|29-OCT-07|(null)|(null)
C41139|Meter|modify|29-OCT-07|(null)|(null)
C48506|Lozenge_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C28253|Milligram|modify|29-OCT-07|(null)|(null)
C28254|Milliliter|modify|29-OCT-07|(null)|(null)
C67310|Million_Units|modify|29-OCT-07|(null)|(null)
C69126|Mutually_Defined|modify|29-OCT-07|(null)|(null)
C19594|Not_Otherwise_Specified|modify|29-OCT-07|(null)|(null)
C48520|Package_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48521|Packet_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48529|Pint|modify|29-OCT-07|(null)|(null)
C48539|Suppository_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48540|Syringe_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48541|Tablespoon_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48542|Tablet_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48544|Teaspoon_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C70626|Transdermal_Patch_Dosing_Unit|create|29-OCT-07|(null)|(null)
C48549|Tube_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C25709|Unit_of_Measure|modify|29-OCT-07|(null)|(null)
C48551|Vial_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C66949|Depsipeptide_PM02734|modify|29-OCT-07|(null)|(null)
C70627|Ph_Unknown_BCR_Negative|create|29-OCT-07|(null)|(null)
C70628|Ph_Unknown_BCR_Unknown|create|29-OCT-07|(null)|(null)
C70629|Ph_Negative_BCR-ABL_Negative|create|29-OCT-07|(null)|(null)
C70630|Ph_Negative_BCR_Unknown|create|29-OCT-07|(null)|(null)
C48230|JPEG|modify|29-OCT-07|(null)|(null)
C70631|TIFF|create|29-OCT-07|(null)|(null)
C2851|AIDS|modify|29-OCT-07|(null)|(null)
C50613|Induced_Abortion|modify|29-OCT-07|(null)|(null)
C70549|Microscopic_Polyarteritis|modify|29-OCT-07|(null)|(null)
C28452|Philadelphia_Chromosome|modify|29-OCT-07|(null)|(null)
C35221|Abortion|modify|29-OCT-07|(null)|(null)
C70632|Alternative_Hematopoietic_Cell_Transplantation|create|29-OCT-07|(null)|(null)
C70633|Nodular_Partial_Remission|create|29-OCT-07|(null)|(null)
C70634|Destructive_Arthritis|create|29-OCT-07|(null)|(null)
C26699|Bacterial_Arthritis|modify|29-OCT-07|(null)|(null)
C27139|Pyogenic_Arthritis|modify|29-OCT-07|(null)|(null)
C70635|Necrotizing_Vasculitis|create|29-OCT-07|(null)|(null)
C70636|Extra-Articular|create|29-OCT-07|(null)|(null)
C70637|Stringent_Complete_Response_sCR_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70638|Very_Good_Partial_Response_VGPR_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70639|Complete_Response_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70640|Plant-Derived_Hematopoiesis_Enhancer_PG2|create|29-OCT-07|(null)|(null)
C70641|Partial_Response_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70642|Stable_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70643|Progression_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70645|Relapse_from_Complete_Response_of_Multiple_Myeloma_or_Plasma_Cell_Leukemia|create|29-OCT-07|(null)|(null)
C70644|CEA-6D_VRP_Vaccine|create|29-OCT-07|(null)|(null)
C70646|CREST_Syndrome|create|29-OCT-07|(null)|(null)
C34819|Mikulicz_Disease|modify|29-OCT-07|(null)|(null)
C70647|Sicca_Syndrome|create|29-OCT-07|(null)|(null)
C64499|As_Necessary|modify|29-OCT-07|(null)|(null)
C64534|Every_Four_Days|modify|29-OCT-07|(null)|(null)
C64530|Four_Times_Daily|modify|29-OCT-07|(null)|(null)
C64533|Every_Three_Days|modify|29-OCT-07|(null)|(null)
C64538|Every_Four_Months|modify|29-OCT-07|(null)|(null)
C64529|Every_Four_Weeks|modify|29-OCT-07|(null)|(null)
C64535|Every_Three_Weeks|modify|29-OCT-07|(null)|(null)
C64537|Every_Three_Months|modify|29-OCT-07|(null)|(null)
C64531|Four_Times_Weekly|modify|29-OCT-07|(null)|(null)
C67069|Weekly|modify|29-OCT-07|(null)|(null)
C64498|Monthly|modify|29-OCT-07|(null)|(null)
C25473|Daily|modify|29-OCT-07|(null)|(null)
C64527|Three_Times_Daily|modify|29-OCT-07|(null)|(null)
C64496|Twice_Daily|modify|29-OCT-07|(null)|(null)
C64497|Twice_Weekly|modify|29-OCT-07|(null)|(null)
C17998|Unknown|modify|29-OCT-07|(null)|(null)
C70648|Lab_Lupus_Inhibitor|create|29-OCT-07|(null)|(null)
C4664|T-Cell_Large_Granular_Lymphocyte_Leukemia|modify|29-OCT-07|(null)|(null)
C70649|T_Cell_Chronic_Lymphocytic_Leukemia|create|29-OCT-07|(null)|(null)
C12423|Nasopharynx|modify|29-OCT-07|(null)|(null)
C33162|Navicular_Bone|modify|29-OCT-07|(null)|(null)
C12299|Nipple|modify|29-OCT-07|(null)|(null)
C33178|Nostril|modify|29-OCT-07|(null)|(null)
C12761|Optic_Nerve|modify|29-OCT-07|(null)|(null)
C52745|Palatine_Bone|modify|29-OCT-07|(null)|(null)
C12320|Parametrium|modify|29-OCT-07|(null)|(null)
C12763|Paranasal_Sinus|modify|29-OCT-07|(null)|(null)
C12354|Parietal_Lobe_of_the_Brain|modify|29-OCT-07|(null)|(null)
C12427|Parotid_Gland|modify|29-OCT-07|(null)|(null)
C33278|Parotid_Gland_Lymph_Node|modify|29-OCT-07|(null)|(null)
C33282|Patella|modify|29-OCT-07|(null)|(null)
C33287|Pelvic_Bone|modify|29-OCT-07|(null)|(null)
C12767|Pelvis|modify|29-OCT-07|(null)|(null)
C13005|Pericardium|modify|29-OCT-07|(null)|(null)
C33301|Perineum|modify|29-OCT-07|(null)|(null)
C12768|Peripheral_Nerve|modify|29-OCT-07|(null)|(null)
C33318|Pharyngeal_Tonsil|modify|29-OCT-07|(null)|(null)
C12425|Pharynx|modify|29-OCT-07|(null)|(null)
C12840|Pleural_Cavity|modify|29-OCT-07|(null)|(null)
C33343|Portal_Vein|modify|29-OCT-07|(null)|(null)
C33433|Pyloric_Sphincter|modify|29-OCT-07|(null)|(null)
C12343|Retina|modify|29-OCT-07|(null)|(null)
C12782|Rib|modify|29-OCT-07|(null)|(null)
C52770|Rib_1|modify|29-OCT-07|(null)|(null)
C52769|Rib_10|modify|29-OCT-07|(null)|(null)
C52768|Rib_11|modify|29-OCT-07|(null)|(null)
C52767|Rib_12|modify|29-OCT-07|(null)|(null)
C52766|Rib_2|modify|29-OCT-07|(null)|(null)
C52765|Rib_3|modify|29-OCT-07|(null)|(null)
C52764|Rib_4|modify|29-OCT-07|(null)|(null)
C52763|Rib_5|modify|29-OCT-07|(null)|(null)
C52762|Rib_6|modify|29-OCT-07|(null)|(null)
C52761|Rib_7|modify|29-OCT-07|(null)|(null)
C52760|Rib_8|modify|29-OCT-07|(null)|(null)
C52759|Rib_9|modify|29-OCT-07|(null)|(null)
C52934|HKR3_wt_Allele|modify|29-OCT-07|(null)|(null)
C70650|Aminopeptidase_Inhibitor_CHR-2797|create|29-OCT-07|(null)|(null)
C2518|GI14721|modify|29-OCT-07|(null)|(null)
C69088|Cost|modify|29-OCT-07|(null)|(null)
C70651|Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin|create|29-OCT-07|(null)|(null)
C64772|Tocopherol_Succinate_7-Ethyl-10-Hydroxycamptothecin|modify|29-OCT-07|(null)|(null)
C18920|Outreach_Research|modify|29-OCT-07|(null)|(null)
C70652|Manager|create|29-OCT-07|(null)|(null)
C70653|Inversion|create|29-OCT-07|(null)|(null)
C70654|Differential_In-Gel_Electrophoresis|create|29-OCT-07|(null)|(null)
C70655|Aurora_Kinase_Inhibitor_SNS-314|create|29-OCT-07|(null)|(null)
C50466|Atrial_Fibrillation|modify|29-OCT-07|(null)|(null)
C70656|Point|create|29-OCT-07|(null)|(null)
C62563|Clinical_Center|modify|29-OCT-07|(null)|(null)
C70657|International_Staging_System_for_Myeloma|create|29-OCT-07|(null)|(null)
C70658|ISS_Stage_I_Plasma_Cell_Myeloma|create|29-OCT-07|(null)|(null)
C70659|ISS_Stage_II_Plasma_Cell_Myeloma|create|29-OCT-07|(null)|(null)
C70660|ISS_Stage_III_Plasma_Cell_Myeloma|create|29-OCT-07|(null)|(null)
C37984|Laboratory|modify|29-OCT-07|(null)|(null)
C70661|Microplate_Reader|create|29-OCT-07|(null)|(null)
C70662|Excitation|create|29-OCT-07|(null)|(null)
C70663|Unique_Identifier|create|29-OCT-07|(null)|(null)
C42718|Concept_Unique_Identifier|modify|29-OCT-07|(null)|(null)
C54177|Lexical_Group_Unique_Identifier|modify|29-OCT-07|(null)|(null)
C54100|Universally_Unique_Identifier|modify|29-OCT-07|(null)|(null)
C42735|Serial_Version_Unique_Identifier|modify|29-OCT-07|(null)|(null)
C47841|Life_Sciences_Identifier|modify|29-OCT-07|(null)|(null)
C54683|International_Chemical_Identifier|modify|29-OCT-07|(null)|(null)
C25402|Accession_Number|modify|29-OCT-07|(null)|(null)
C63540|caBIG_Identifier|modify|29-OCT-07|(null)|(null)
C54682|CAS_Number|modify|29-OCT-07|(null)|(null)
C54633|National_Provider_Identifier|modify|29-OCT-07|(null)|(null)
C41189|Study_Subject|modify|29-OCT-07|(null)|(null)
C25392|Manufacturer_Name|modify|29-OCT-07|(null)|(null)
C45525|Valvular_Heart_Disorder|modify|29-OCT-07|(null)|(null)
C26976|Chronic_Obstructive_Asthma|modify|29-OCT-07|(null)|(null)
C28397|Asthma|modify|29-OCT-07|(null)|(null)
C35605|Glomerular_Vascular_Disorder|modify|29-OCT-07|(null)|(null)
C70664|Relevance|create|29-OCT-07|(null)|(null)
C61376|Moderation|modify|29-OCT-07|(null)|(null)
C70666|Mild|create|29-OCT-07|(null)|(null)
C70665|Human_Study_Subject|create|29-OCT-07|(null)|(null)
C70667|Severe|create|29-OCT-07|(null)|(null)
C3198|Lung_Disorder|modify|29-OCT-07|(null)|(null)
C3149|Renal_Disorder|modify|29-OCT-07|(null)|(null)
C12853|Sacral_Vertebra|modify|29-OCT-07|(null)|(null)
C33507|Sacroiliac_Joint|modify|29-OCT-07|(null)|(null)
C33508|Sacrum|modify|29-OCT-07|(null)|(null)
C12854|Scaphoid_Bone|modify|29-OCT-07|(null)|(null)
C12783|Scapula|modify|29-OCT-07|(null)|(null)
C12785|Scrotum|modify|29-OCT-07|(null)|(null)
C52810|Sciatic_Nerve|modify|29-OCT-07|(null)|(null)
C33548|Shoulder_Joint|modify|29-OCT-07|(null)|(null)
C33556|Sinus|modify|29-OCT-07|(null)|(null)
C12295|Skin_of_the_Trunk|modify|29-OCT-07|(null)|(null)
C12789|Skull|modify|29-OCT-07|(null)|(null)
C12386|Small_Intestine|modify|29-OCT-07|(null)|(null)
C52730|Sternal_Manubrium|modify|29-OCT-07|(null)|(null)
C33615|Sternoclavicular_Joint|modify|29-OCT-07|(null)|(null)
C12793|Sternum|modify|29-OCT-07|(null)|(null)
C12391|Stomach|modify|29-OCT-07|(null)|(null)
C12280|Subglottis|modify|29-OCT-07|(null)|(null)
C33718|Synovial_Fluid|modify|29-OCT-07|(null)|(null)
C33720|T1_Vertebra|modify|29-OCT-07|(null)|(null)
C33721|T10_Vertebra|modify|29-OCT-07|(null)|(null)
C33722|T11_Vertebra|modify|29-OCT-07|(null)|(null)
C33723|T12_Vertebra|modify|29-OCT-07|(null)|(null)
C33724|T2_Vertebra|modify|29-OCT-07|(null)|(null)
C33725|T3_Vertebra|modify|29-OCT-07|(null)|(null)
C33726|T4_Vertebra|modify|29-OCT-07|(null)|(null)
C33727|T5_Vertebra|modify|29-OCT-07|(null)|(null)
C33728|T6_Vertebra|modify|29-OCT-07|(null)|(null)
C33729|T7_Vertebra|modify|29-OCT-07|(null)|(null)
C33730|T8_Vertebra|modify|29-OCT-07|(null)|(null)
C33731|T9_Vertebra|modify|29-OCT-07|(null)|(null)
C52799|Talus|modify|29-OCT-07|(null)|(null)
C33737|Tarsus_Bone|modify|29-OCT-07|(null)|(null)
C12797|Temporal_Bone|modify|29-OCT-07|(null)|(null)
C12459|Thalamus|modify|29-OCT-07|(null)|(null)
C33763|Thigh|modify|29-OCT-07|(null)|(null)
C12798|Thoracic_Vertebra|modify|29-OCT-07|(null)|(null)
C12799|Thorax|modify|29-OCT-07|(null)|(null)
C54272|Throat|modify|29-OCT-07|(null)|(null)
C70669|Automatic|create|29-OCT-07|(null)|(null)
C12400|Thyroid_Gland|modify|29-OCT-07|(null)|(null)
C12800|Tibia|modify|29-OCT-07|(null)|(null)
C33788|Toe|modify|29-OCT-07|(null)|(null)
C33790|Toe_Nail|modify|29-OCT-07|(null)|(null)
C12428|Trachea|modify|29-OCT-07|(null)|(null)
C12857|Trapezial_Bone|modify|29-OCT-07|(null)|(null)
C33809|Trapezius_Muscle|modify|29-OCT-07|(null)|(null)
C70670|Always|create|29-OCT-07|(null)|(null)
C12859|Trapezoid_Bone|modify|29-OCT-07|(null)|(null)
C12858|Triangular_Bone|modify|29-OCT-07|(null)|(null)
C33814|Trochanter|modify|29-OCT-07|(null)|(null)
C12808|Trochlear_Nerve|modify|29-OCT-07|(null)|(null)
C33200|Olecranon|modify|29-OCT-07|(null)|(null)
C62432|Uncinate_Pancreas|modify|29-OCT-07|(null)|(null)
C12416|Ureter|modify|29-OCT-07|(null)|(null)
C12417|Urethra|modify|29-OCT-07|(null)|(null)
C12413|Urinary_System|modify|29-OCT-07|(null)|(null)
C12405|Uterus|modify|29-OCT-07|(null)|(null)
C12811|Uvea|modify|29-OCT-07|(null)|(null)
C12814|Vein|modify|29-OCT-07|(null)|(null)
C12998|Vertebral_Column|modify|29-OCT-07|(null)|(null)
C12822|Vocal_Cord|modify|29-OCT-07|(null)|(null)
C33888|Vomer|modify|29-OCT-07|(null)|(null)
C12408|Vulva|modify|29-OCT-07|(null)|(null)
C70668|Human_Clinical_Study_Subject|create|29-OCT-07|(null)|(null)
C70671|Bead|create|29-OCT-07|(null)|(null)
C70672|Pore|create|29-OCT-07|(null)|(null)
C70673|Stationary_Phase|create|29-OCT-07|(null)|(null)
C70674|Recombinant_Human_EGF-rP64K_Montanide_ISA_51_Vaccine|create|29-OCT-07|(null)|(null)
C70675|Gadobutrol|create|29-OCT-07|(null)|(null)
C70676|Ex_vivo|create|29-OCT-07|(null)|(null)
C70677|Micronutrient-Fortified_Probiotic_Yogurt|create|29-OCT-07|(null)|(null)
C15263|in_vitro|modify|29-OCT-07|(null)|(null)
C15744|in_vivo|modify|29-OCT-07|(null)|(null)
C70678|Potential_Clinical_Study_Subject|create|29-OCT-07|(null)|(null)
C70679|Authorization_for_Release_of_Confidential_Health_Information|create|29-OCT-07|(null)|(null)
C70680|Healthcare_Payment_Method|create|29-OCT-07|(null)|(null)
C17752|Fee_for_Service|modify|29-OCT-07|(null)|(null)
C70681|Per_Diem_Payment_Method|create|29-OCT-07|(null)|(null)
C70682|Episode_of_Care_Payment_Method|create|29-OCT-07|(null)|(null)
C70683|Condition-Specific_Capitation_Payment_Method|create|29-OCT-07|(null)|(null)
C70684|Capitation_Payment_Method|create|29-OCT-07|(null)|(null)
C69411|Unit_of_Specific_Radioactivity|modify|29-OCT-07|(null)|(null)
C19579|Direct_Costs|modify|29-OCT-07|(null)|(null)
C19484|Facilities_and_Administrative_Costs|modify|29-OCT-07|(null)|(null)
C19336|Head_and_Neck_Subset_of_Total|modify|29-OCT-07|(null)|(null)
C19190|Lung_Cancer_Women_Subset_of_Total_Lung|modify|29-OCT-07|(null)|(null)
C70685|HLA-A31_Positive_Cells|create|29-OCT-07|(null)|(null)
C64896|Exercise_Therapy|modify|29-OCT-07|(null)|(null)
C16746|Insurance_Health_Reimbursement|modify|29-OCT-07|(null)|(null)
C70686|Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70687|Waiver_of_Authorization_for_Release_of_Confidential_Health_Information|create|29-OCT-07|(null)|(null)
C68633|Medicaid|modify|29-OCT-07|(null)|(null)
C16745|Insurance|modify|29-OCT-07|(null)|(null)
C16665|Medicare|modify|29-OCT-07|(null)|(null)
C70688|Primary_Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70689|Quadrupole|create|29-OCT-07|(null)|(null)
C70690|Secondary_Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70691|Third_Party_Healthcare_Payer|create|29-OCT-07|(null)|(null)
C70692|Workers_Compensation_Plan|create|29-OCT-07|(null)|(null)
C70693|Gradient|create|29-OCT-07|(null)|(null)
C70694|Managed_Healthcare_Plan|create|29-OCT-07|(null)|(null)
C70695|Social_Managed_Healthcare_Plan|create|29-OCT-07|(null)|(null)
C70696|Private_Health_Insurance|create|29-OCT-07|(null)|(null)
C70697|Reflectron|create|29-OCT-07|(null)|(null)
C70698|Time-of-Flight|create|29-OCT-07|(null)|(null)
C70699|Biospecimen|create|29-OCT-07|(null)|(null)
C18202|Biopsy_Specimen|modify|29-OCT-07|(null)|(null)
C25436|Blocks|modify|29-OCT-07|(null)|(null)
C17610|Blood_Sample|modify|29-OCT-07|(null)|(null)
C13195|Bronchoalveolar_Lavage_Fluid|modify|29-OCT-07|(null)|(null)
C17169|Cell_Fraction|modify|29-OCT-07|(null)|(null)
C16403|Cell_Line|modify|29-OCT-07|(null)|(null)
C53471|Isolate|modify|29-OCT-07|(null)|(null)
C45910|Pooled_Sample|modify|29-OCT-07|(null)|(null)
C25668|Section|modify|29-OCT-07|(null)|(null)
C25682|Slice|modify|29-OCT-07|(null)|(null)
C19697|Tissue_Sample|modify|29-OCT-07|(null)|(null)
C62755|Unstained_Specimen|modify|29-OCT-07|(null)|(null)
C70700|Method_of_Biospecimen_Collection|create|29-OCT-07|(null)|(null)
C70701|Fasting_Specimen|create|29-OCT-07|(null)|(null)
C70702|Non-Fasting_Specimen|create|29-OCT-07|(null)|(null)
C70703|Clinical_Study_Status|create|29-OCT-07|(null)|(null)
C70704|Planned_Clinical_Study|create|29-OCT-07|(null)|(null)
C70705|Component_of_Clinical_Study_Protocol|create|29-OCT-07|(null)|(null)
C70706|Clinical_Study_Targeted_Accrual|create|29-OCT-07|(null)|(null)
C70707|Planned_Duration_of_Study_Subject_Participation|create|29-OCT-07|(null)|(null)
C70708|Planned_Intervention_Duration_for_Study_Subject|create|29-OCT-07|(null)|(null)
C70709|Submission_Unit|create|29-OCT-07|(null)|(null)
C70710|Sequence_Number|create|29-OCT-07|(null)|(null)
C70711|Activity_Status|create|29-OCT-07|(null)|(null)
C70712|Status_of_Scheduled_Study_Activity_for_Study_Subject|create|29-OCT-07|(null)|(null)
C70713|Biospecimen_Type|create|29-OCT-07|(null)|(null)
C70714|Biospecimen_Condition|create|29-OCT-07|(null)|(null)
C70715|Lipemic_Specimen|create|29-OCT-07|(null)|(null)
C70716|Leaking_Specimen|create|29-OCT-07|(null)|(null)
C70717|Frozen_Specimen|create|29-OCT-07|(null)|(null)
C70718|Refrigerated_Specimen|create|29-OCT-07|(null)|(null)
C70719|Specimen_at_Room_Temperature|create|29-OCT-07|(null)|(null)
C70720|Hemolysis_in_Specimen|create|29-OCT-07|(null)|(null)
C70721|Reviewable_Unit|create|29-OCT-07|(null)|(null)
C70722|Investigator_by_Role_in_Study|create|29-OCT-07|(null)|(null)
C51812|Co-Investigator|modify|29-OCT-07|(null)|(null)
C19924|Principal_Investigator|modify|29-OCT-07|(null)|(null)
C51817|Contract_Principal_Investigator|modify|29-OCT-07|(null)|(null)
C51818|Coordinating_Investigator|modify|29-OCT-07|(null)|(null)
C51825|Grant_Investigator|modify|29-OCT-07|(null)|(null)
C51856|Protocol_Lead_Investigator|modify|29-OCT-07|(null)|(null)
C51875|Site_Representative_Investigator|modify|29-OCT-07|(null)|(null)
C54622|Subinvestigator|modify|29-OCT-07|(null)|(null)
C51826|Grant_Principal_Investigator|modify|29-OCT-07|(null)|(null)
C70723|Investigator_Status|create|29-OCT-07|(null)|(null)
C70724|Investigator_Registration_Status|create|29-OCT-07|(null)|(null)
C70725|Investigator_Status_in_Study|create|29-OCT-07|(null)|(null)
C70726|Planned_Clinical_Study_Activity|create|29-OCT-07|(null)|(null)
C70727|Assessment_of_Observation_Result|create|29-OCT-07|(null)|(null)
C70728|Information_Status|create|29-OCT-07|(null)|(null)
C70729|Targeted_Anatomic_Site|create|29-OCT-07|(null)|(null)
C70730|Clinical_Study_Population_Subgroup|create|29-OCT-07|(null)|(null)
C70731|Subject_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70732|Study_Subject_Participation_Status|create|29-OCT-07|(null)|(null)
C70733|Subject_Screened_for_Study|create|29-OCT-07|(null)|(null)
C70734|Active_Subject_Participation_Status|create|29-OCT-07|(null)|(null)
C70735|Subject_Completed_Participation_in_Study|create|29-OCT-07|(null)|(null)
C70736|Subject_Participation_Terminated|create|29-OCT-07|(null)|(null)
C70737|Permanent_Intervention_Discontinuation_Subject_Continues_Follow_Up|create|29-OCT-07|(null)|(null)
C70738|Permanent_Intervention_Discontinuation_due_to_Adverse_Event_Subject_Continues_Follow_Up|create|29-OCT-07|(null)|(null)
C70739|Permanent_Intervention_Discontinuation_No_Subject_Follow_Up|create|29-OCT-07|(null)|(null)
C70740|Subject_Lost_to_Follow_Up|create|29-OCT-07|(null)|(null)
C70741|Anti-CD20_Monoclonal_Antibody_R7159|create|29-OCT-07|(null)|(null)
C70742|Treat|create|29-OCT-07|(null)|(null)
C70743|Milestone|create|29-OCT-07|(null)|(null)
C70744|Slope|create|29-OCT-07|(null)|(null)
C70745|Approved_Protocol|create|29-OCT-07|(null)|(null)
C70746|Protocol_Approved_with_Modifications|create|29-OCT-07|(null)|(null)
C70747|Active_Study|create|29-OCT-07|(null)|(null)
C70749|Contour|create|29-OCT-07|(null)|(null)
C70748|Protocol_Disapproved|create|29-OCT-07|(null)|(null)
C70750|Protocol_Deferred|create|29-OCT-07|(null)|(null)
C70751|Study_Closed_to_Accrual|create|29-OCT-07|(null)|(null)
C70752|Study_Closed_to_Accrual_and_Treatment|create|29-OCT-07|(null)|(null)
C70753|Brightness|create|29-OCT-07|(null)|(null)
C70754|Contrast|create|29-OCT-07|(null)|(null)
C70755|Study_on_Hold|create|29-OCT-07|(null)|(null)
C54116|Match|modify|29-OCT-07|(null)|(null)
C70756|Study_Completed|create|29-OCT-07|(null)|(null)
C70757|Study_Terminated|create|29-OCT-07|(null)|(null)
C70758|Study_Withdrawn|create|29-OCT-07|(null)|(null)
C70759|Performed_Clinical_Study|create|29-OCT-07|(null)|(null)
C70761|Digital_Tomosynthesis_Mammography|create|29-OCT-07|(null)|(null)
C50332|CPU|modify|29-OCT-07|(null)|(null)
C49897|Central_Processing_Unit_Board|modify|29-OCT-07|(null)|(null)
C70760|Clinical_Study_Actual_Accrual_Number|create|29-OCT-07|(null)|(null)
C70762|Clinical_Study_Activity_Relationship|create|29-OCT-07|(null)|(null)
C70763|Priority_Number|create|29-OCT-07|(null)|(null)
C70764|Free_Text_Format|create|29-OCT-07|(null)|(null)
C70765|Clinical_Study_Document_Relationship|create|29-OCT-07|(null)|(null)
C70766|Quantitative|create|29-OCT-07|(null)|(null)
C42541|International_System_of_Units|modify|29-OCT-07|(null)|(null)
C70767|System_of_Measurement|create|29-OCT-07|(null)|(null)
C70768|Laboratory_Test_Result_Status|create|29-OCT-07|(null)|(null)
C70769|Unit_by_System_of_Measurement|create|29-OCT-07|(null)|(null)
C42532|Unit_of_International_System_of_Units|modify|29-OCT-07|(null)|(null)
C70770|Original_Unit_or_Value_of_Reported_Test_Result|create|29-OCT-07|(null)|(null)
C70772|Knowledge_Field|create|29-OCT-07|(null)|(null)
C25507|Field|split|29-OCT-07|C70772|Knowledge_Field
C25507|Field|split|29-OCT-07|C25507|Field
C25507|Field|split|29-OCT-07|C25507|Field
C70771|Standard_Unit_or_Value_of_Test_Result|create|29-OCT-07|(null)|(null)
C70773|Field_Force|create|29-OCT-07|(null)|(null)
C25507|Field|split|29-OCT-07|C70773|Field_Force
C70774|Unit_Conversion_Factor|create|29-OCT-07|(null)|(null)
C70775|Brownian_Dynamics|create|29-OCT-07|(null)|(null)
C70776|Observation_Outcome_Relationship|create|29-OCT-07|(null)|(null)
C70777|Clinical_Study_Site|create|29-OCT-07|(null)|(null)
C70778|Protocol_Administratively_Withdrawn|create|29-OCT-07|(null)|(null)
C70779|Protocol_Conditionally_Approved|create|29-OCT-07|(null)|(null)
C70780|Laboratory-Generated|create|29-OCT-07|(null)|(null)
C70781|Clinical_Study_Site_by_Role_in_Study|create|29-OCT-07|(null)|(null)
C70783|Clinical_Study_Site_Status|create|29-OCT-07|(null)|(null)
C70785|Clinical_Study_Site_Accrual_Status|create|29-OCT-07|(null)|(null)
C70785|Clinical_Study_Site_Accrual_Status|merge|29-OCT-07|C70785|Clinical_Study_Site_Accrual_Status
C70786|Study_Site_Open_to_Accrual|create|29-OCT-07|(null)|(null)
C70787|Study_Site_Closed_to_Accrual|create|29-OCT-07|(null)|(null)
C70788|Study_Site_Temporarily_Closed_to_Accrual|create|29-OCT-07|(null)|(null)
C70789|Targeted_Accrual_at_Clinical_Study_Site|create|29-OCT-07|(null)|(null)
C70790|Clinical_Study_Lead_Organization|create|29-OCT-07|(null)|(null)
C70791|Participating_Clinical_Study_Organization|create|29-OCT-07|(null)|(null)
C70792|Anti-VEGFR-2_Fully_Human_Monoclonal_Antibody_IMC-1121B|create|29-OCT-07|(null)|(null)
C70793|Clinical_Study_Sponsor|create|29-OCT-07|(null)|(null)
C70794|Primary_Clinical_Study_Sponsor|create|29-OCT-07|(null)|(null)
C70795|Secondary_Clinical_Study_Sponsor|create|29-OCT-07|(null)|(null)
C70796|Eluent|create|29-OCT-07|(null)|(null)
C70797|CD20-targeted_Compound_TRU-015|create|29-OCT-07|(null)|(null)
C70798|Anti-CD45_Monoclonal_Antibody|create|29-OCT-07|(null)|(null)
C70799|Approval_Document|create|29-OCT-07|(null)|(null)
C16741|Institutional_Review_Board|modify|29-OCT-07|(null)|(null)
C70800|Institutional_Review_Board_Approval|create|29-OCT-07|(null)|(null)
C70801|Institutional_Review_Board_Approval_Date|create|29-OCT-07|(null)|(null)
C70802|Clinical_Study_Site_Active|create|29-OCT-07|(null)|(null)
C70803|Clinical_Study_Site_Pending_IRB_Approval|create|29-OCT-07|(null)|(null)
C70804|Site_Participation_in_Clinical_Study_Cancelled|create|29-OCT-07|(null)|(null)
C70805|Letter|create|29-OCT-07|(null)|(null)
C47927|Ionization_Source|modify|29-OCT-07|(null)|(null)
C48046|Pair|modify|29-OCT-07|(null)|(null)
C70806|Telecommunication_Address|create|29-OCT-07|(null)|(null)
C70808|Telecommunication_Address_Usage_Type|create|29-OCT-07|(null)|(null)
C70809|Communication_Resource_Usage_Type|create|29-OCT-07|(null)|(null)
C70810|Date_of_Death|create|29-OCT-07|(null)|(null)
C70811|Household_Income|create|29-OCT-07|(null)|(null)
C19308|Average_Household_Income|modify|29-OCT-07|(null)|(null)
C15529|Bone_Metastases_Prevention|modify|29-OCT-07|(null)|(null)
C70812|Bone_Metastases_Treatment|create|29-OCT-07|(null)|(null)
C37452|Ixabepilone|modify|29-OCT-07|(null)|(null)
C70813|Voltage|create|29-OCT-07|(null)|(null)
C70814|Regulated_Industry|create|29-OCT-07|(null)|(null)
C70815|Buffer|create|29-OCT-07|(null)|(null)
C70816|Regulated_Industry_Unique_Identifier|create|29-OCT-07|(null)|(null)
C25320|Protocol|modify|29-OCT-07|(null)|(null)
C34070|Cell_Part|modify|29-OCT-07|(null)|(null)
C32283|Centriole|modify|29-OCT-07|(null)|(null)
C32285|Centrosome|modify|29-OCT-07|(null)|(null)
C20180|Cell_Cycle_Stage|modify|29-OCT-07|(null)|(null)
C70817|Study_Protocol|create|29-OCT-07|(null)|(null)
C70818|Terminology_Concept_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70819|Clinical_Study_by_Targeted_Disease_or_Condition|create|29-OCT-07|(null)|(null)
C70820|Clinical_Study_by_Phase|create|29-OCT-07|(null)|(null)
C70821|Clinical_Study_by_Design|create|29-OCT-07|(null)|(null)
C15206|Clinical_Study|modify|29-OCT-07|(null)|(null)
C51359|AIDS_Clinical_Trial|modify|29-OCT-07|(null)|(null)
C15790|Cancer_Prevention_Trial|modify|29-OCT-07|(null)|(null)
C16095|Clinical_Trials_Cancer_Control|modify|29-OCT-07|(null)|(null)
C16096|Clinical_Trials_Cancer_Treatment|modify|29-OCT-07|(null)|(null)
C16140|Intervention_Trial|modify|29-OCT-07|(null)|(null)
C70824|Clinical_Study_by_Organizational_Parameters|create|29-OCT-07|(null)|(null)
C16104|Multi-Institutional_Clinical_Trial|modify|29-OCT-07|(null)|(null)
C54721|Phase_0_Trial|modify|29-OCT-07|(null)|(null)
C15693|Phase_I_II_Trial|modify|29-OCT-07|(null)|(null)
C15600|Phase_I_Trial|modify|29-OCT-07|(null)|(null)
C15694|Phase_II_III_Trial|modify|29-OCT-07|(null)|(null)
C15601|Phase_II_Trial|modify|29-OCT-07|(null)|(null)
C15602|Phase_III_Trial|modify|29-OCT-07|(null)|(null)
C15603|Phase_IV_Trial|modify|29-OCT-07|(null)|(null)
C47865|Phase_V_Trial|modify|29-OCT-07|(null)|(null)
C15417|Randomized_Clinical_Trial|modify|29-OCT-07|(null)|(null)
C15864|Vaccine_Clinical_Trial|modify|29-OCT-07|(null)|(null)
C15835|Phase_I_and_II_Vaccine_Trials|modify|29-OCT-07|(null)|(null)
C15873|Vaccine_Trial-Phase_III_Large_Scale|modify|29-OCT-07|(null)|(null)
C15234|Follow-up_Study|modify|29-OCT-07|(null)|(null)
C39421|Human_Pharmacology_Study|modify|29-OCT-07|(null)|(null)
C16003|Infectious_Diseases_Research|modify|29-OCT-07|(null)|(null)
C16123|Clinical_Trials_Other|modify|29-OCT-07|(null)|(null)
C15829|Outcomes_and_Health_Services_Research|modify|29-OCT-07|(null)|(null)
C15285|Nursing_Research|modify|29-OCT-07|(null)|(null)
C16016|Nutrition_Vitamins|modify|29-OCT-07|(null)|(null)
C15820|Nutritional_Study|modify|29-OCT-07|(null)|(null)
C29884|Vaccinia_Virus_Study|modify|29-OCT-07|(null)|(null)
C15985|Nicotine_Dependence_Addiction_on_Treatment|modify|29-OCT-07|(null)|(null)
C15961|Rehabilitation_Research|modify|29-OCT-07|(null)|(null)
C39539|Therapeutic_Use_Study|modify|29-OCT-07|(null)|(null)
C39537|Therapeutic_Confirmatory_Study|modify|29-OCT-07|(null)|(null)
C39538|Therapeutic_Exploratory_Study|modify|29-OCT-07|(null)|(null)
C39536|Therapeutic_Clinical_Trial|modify|29-OCT-07|(null)|(null)
C49698|Study_Stop_Rules|modify|29-OCT-07|(null)|(null)
C16041|Ancillary_Study|modify|29-OCT-07|(null)|(null)
C16141|Pain_Research|modify|29-OCT-07|(null)|(null)
C49647|Control_Type|modify|29-OCT-07|(null)|(null)
C49697|Trial_Length|modify|29-OCT-07|(null)|(null)
C49691|Trial_Summary_Parameter|modify|29-OCT-07|(null)|(null)
C15303|Pilot_Study|modify|29-OCT-07|(null)|(null)
C48678|Preclinical_Study|modify|29-OCT-07|(null)|(null)
C49660|Trial_Type|modify|29-OCT-07|(null)|(null)
C49665|Therapeutic_Equivalency_Study|modify|29-OCT-07|(null)|(null)
C49653|Diagnosis_Study|modify|29-OCT-07|(null)|(null)
C70825|American_Society_of_Anesthesiologists|create|29-OCT-07|(null)|(null)
C43384|Acquisition|modify|29-OCT-07|(null)|(null)
C70826|Fit|create|29-OCT-07|(null)|(null)
C70827|Recovery_Generic|create|29-OCT-07|(null)|(null)
C70828|Curve_Mathematical|create|29-OCT-07|(null)|(null)
C16163|Polyp_Prevention_Trial|modify|29-OCT-07|(null)|(null)
C53480|Met_Decision_Criteria_for_Secondary_Outcome_Variable|modify|29-OCT-07|(null)|(null)
C53476|Met_Decision_Criteria_for_Primary_Outcome_Variable|modify|29-OCT-07|(null)|(null)
C49664|Bioavailability_Study|modify|29-OCT-07|(null)|(null)
C49662|Pharmacodynamic_Study|modify|29-OCT-07|(null)|(null)
C49661|Pharmacogenomic_Study|modify|29-OCT-07|(null)|(null)
C49663|Pharmacokinetic_Study|modify|29-OCT-07|(null)|(null)
C49667|Safety_Study|modify|29-OCT-07|(null)|(null)
C49648|Placebo_Control|modify|29-OCT-07|(null)|(null)
C49649|Active_Control|modify|29-OCT-07|(null)|(null)
C28280|Uncontrolled_Study|modify|29-OCT-07|(null)|(null)
C63552|Reading_Frame|modify|29-OCT-07|(null)|(null)
C13292|Open_Reading_Frame|modify|29-OCT-07|(null)|(null)
C37939|Date_Time|modify|29-OCT-07|(null)|(null)
C19520|Early_Detection_Branch|modify|29-OCT-07|(null)|(null)
C39409|Funding_Agency|modify|29-OCT-07|(null)|(null)
C70829|Protocol_Information_Office|create|29-OCT-07|(null)|(null)
C25407|Address|modify|29-OCT-07|(null)|(null)
C25393|Comments|modify|29-OCT-07|(null)|(null)
C43610|Certification|modify|29-OCT-07|(null)|(null)
C25218|Procedure|modify|29-OCT-07|(null)|(null)
C20200|Outcome|modify|29-OCT-07|(null)|(null)
C48045|Precision|modify|29-OCT-07|(null)|(null)
C54722|Low|modify|29-OCT-07|(null)|(null)
C68850|True|modify|29-OCT-07|(null)|(null)
C68851|False|modify|29-OCT-07|(null)|(null)
C17049|Race|modify|29-OCT-07|(null)|(null)
C70830|Solution|create|29-OCT-07|(null)|(null)
C70831|Amplitude|create|29-OCT-07|(null)|(null)
C70832|Radio_Frequency|create|29-OCT-07|(null)|(null)
C49480|Category_for_Inclusion_and_or_Exclusion|modify|29-OCT-07|(null)|(null)
C16112|Clinical_Trial_Eligibility_Criteria|modify|29-OCT-07|(null)|(null)
C25370|Exclusion|modify|29-OCT-07|(null)|(null)
C25532|Inclusion|modify|29-OCT-07|(null)|(null)
C70833|Study_Population|create|29-OCT-07|(null)|(null)
C70834|Description_of_Study_Population|create|29-OCT-07|(null)|(null)
C70835|Study_Subject_Type|create|29-OCT-07|(null)|(null)
C70836|Autologous_LMP1-LMP2-Specific_Cytotoxic_T-Lymphocytes|create|29-OCT-07|(null)|(null)
C62769|Allogeneic_Epstein-Barr_Virus-Specific_Cytotoxic_T_Lymphocytes|modify|29-OCT-07|(null)|(null)
C70837|Sample_Study_Population|create|29-OCT-07|(null)|(null)
C70838|Image_Feature|create|29-OCT-07|(null)|(null)
C70839|Ion_Trap|create|29-OCT-07|(null)|(null)
C49068|Blinded|modify|29-OCT-07|(null)|(null)
C70841|Hexapole|create|29-OCT-07|(null)|(null)
C70840|Blinded_Clinical_Study|create|29-OCT-07|(null)|(null)
C70842|Net|create|29-OCT-07|(null)|(null)
C70843|Chromint_Software|create|29-OCT-07|(null)|(null)
C41201|Monitor|modify|29-OCT-07|(null)|(null)
C41161|Protocol_Agent|modify|29-OCT-07|(null)|(null)
C64914|Remove|modify|29-OCT-07|(null)|(null)
C70844|Lead_Study_Agent|create|29-OCT-07|(null)|(null)
C20090|Cancer_Trials_Support_Unit|modify|29-OCT-07|(null)|(null)
C70845|Protein_Digestion|create|29-OCT-07|(null)|(null)
C68835|Tryptic_Digestion|modify|29-OCT-07|(null)|(null)
C49936|Electrode_Device_Component|modify|29-OCT-07|(null)|(null)
C41396|Lot|modify|29-OCT-07|(null)|(null)
C70846|Electrode_Grid|create|29-OCT-07|(null)|(null)
C70847|Streak|create|29-OCT-07|(null)|(null)
C70848|Lot_Number|create|29-OCT-07|(null)|(null)
C70849|Cone_Shape|create|29-OCT-07|(null)|(null)
C70850|CD25-Positive_Neoplastic_Cells_Present|create|29-OCT-07|(null)|(null)
C65101|Spray|modify|29-OCT-07|(null)|(null)
C70851|B44-Positive_Neoplastic_Cells_Present|create|29-OCT-07|(null)|(null)
C50324|Tip_Device_Component|modify|29-OCT-07|(null)|(null)
C70852|HLA-A3_A11_Positive_Cells_Present|create|29-OCT-07|(null)|(null)
C70853|Medical_Product_Stability|create|29-OCT-07|(null)|(null)
C42693|Pharmaceutical_Product_Expiration_Date|modify|29-OCT-07|(null)|(null)
C70854|Medical_Product_Expiration_Date|create|29-OCT-07|(null)|(null)
C70855|Medical_Product_Shelf_Life|create|29-OCT-07|(null)|(null)
C70856|Observation_Result|create|29-OCT-07|(null)|(null)
C70857|Date_of_Report|create|29-OCT-07|(null)|(null)
C42540|Metric_System|modify|29-OCT-07|(null)|(null)
C70858|Uncertainty_of_Observation_Result|create|29-OCT-07|(null)|(null)
C70859|Type_of_Regulatory_Submission_Unit|create|29-OCT-07|(null)|(null)
C19711|Professional_Organization_or_Group|modify|29-OCT-07|(null)|(null)
C25694|Submission|modify|29-OCT-07|(null)|(null)
C70860|Original_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70861|Amendment_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70862|Supplemental_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C25405|Activation_Date|modify|29-OCT-07|(null)|(null)
C70863|Regulatory_Submission_Date|create|29-OCT-07|(null)|(null)
C70864|Regulatory_Submission_Receipt_Date|create|29-OCT-07|(null)|(null)
C70865|Document_Status|create|29-OCT-07|(null)|(null)
C70866|Submission_Unit_Status|create|29-OCT-07|(null)|(null)
C70867|Application_Document|create|29-OCT-07|(null)|(null)
C60755|Application_Form|modify|29-OCT-07|(null)|(null)
C19734|Grants_Applications|modify|29-OCT-07|(null)|(null)
C70868|Regulatory_Application|create|29-OCT-07|(null)|(null)
C70869|Regulatory_Submission_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70870|Regulatory_Application_Unique_Identifier|create|29-OCT-07|(null)|(null)
C70871|Type_of_Regulatory_Application|create|29-OCT-07|(null)|(null)
C70872|Device_Classification_513_G_CDRH|create|29-OCT-07|(null)|(null)
C70873|New_Device_Application_CDRH|create|29-OCT-07|(null)|(null)
C70874|Premarket_Notification_Submission|create|29-OCT-07|(null)|(null)
C70875|Product_Development_Protocol|create|29-OCT-07|(null)|(null)
C70876|Reclassification_Petition|create|29-OCT-07|(null)|(null)
C70877|Drug_Master_File|create|29-OCT-07|(null)|(null)
C70878|Investigational_Device_Exemption_520_G_CDRH|create|29-OCT-07|(null)|(null)
C70879|Investigational_Device-Exemption_520_L|create|29-OCT-07|(null)|(null)
C70880|Premarket_Approval_Application|create|29-OCT-07|(null)|(null)
C70881|New_Drug_Application_CBER|create|29-OCT-07|(null)|(null)
C70882|New_Drug_Application_CDER|create|29-OCT-07|(null)|(null)
C70883|Investigational_New_Drug_Exemption_CDER|create|29-OCT-07|(null)|(null)
C70884|Investigational_New_Drug_Exemption_CBER|create|29-OCT-07|(null)|(null)
C70885|Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70886|Type_of_Regulatory_Submission|create|29-OCT-07|(null)|(null)
C70887|Regulatory_Assessment|create|29-OCT-07|(null)|(null)
C49341|Low-Dose_Treatment|modify|29-OCT-07|(null)|(null)
C49342|Moderate-Dose_Treatment|modify|29-OCT-07|(null)|(null)
C70888|Daily_Dose|create|29-OCT-07|(null)|(null)
C54346|Dose_Modification|modify|29-OCT-07|(null)|(null)
C49703|Test_Product_Added_to_Existing_Treatment|modify|29-OCT-07|(null)|(null)
C70889|Agent_Dose_Decreased|create|29-OCT-07|(null)|(null)
C70890|Agent_Dose_Increased|create|29-OCT-07|(null)|(null)
C70891|Agent_Dose_Tapered|create|29-OCT-07|(null)|(null)
C70892|Type_of_Agent_Dose_Change|create|29-OCT-07|(null)|(null)
C70893|Unplanned_Change_of_Dose_Made|create|29-OCT-07|(null)|(null)
C70894|Planned_Change_of_Dose_Made|create|29-OCT-07|(null)|(null)
C43376|Biologically-Derived_Material|modify|29-OCT-07|(null)|(null)
C70895|Code_System|create|29-OCT-07|(null)|(null)
C70896|Display_Name|create|29-OCT-07|(null)|(null)
C70897|Code_Qualifier|create|29-OCT-07|(null)|(null)
C70898|Code_Translation|create|29-OCT-07|(null)|(null)
C70899|Document|create|29-OCT-07|(null)|(null)
C25480|Details|modify|29-OCT-07|(null)|(null)
C70900|Performed_Clinical_Study_Activity|create|29-OCT-07|(null)|(null)
C70901|Study_Activity_Cause_or_Rational|create|29-OCT-07|(null)|(null)
C70902|Concomitant_Agent|create|29-OCT-07|(null)|(null)
C70903|Root_Identifier|create|29-OCT-07|(null)|(null)
C70904|Identifier_Extension|create|29-OCT-07|(null)|(null)
C43377|Microplate|modify|29-OCT-07|(null)|(null)
C12447|Basal_Ganglia|modify|29-OCT-07|(null)|(null)
C12274|Middle_Ear|modify|29-OCT-07|(null)|(null)
C70905|Myringotomy|create|29-OCT-07|(null)|(null)
C33895|Xiphoid_Process|modify|29-OCT-07|(null)|(null)
C12817|Vena_Cava|modify|29-OCT-07|(null)|(null)
C12838|Radial_Artery|modify|29-OCT-07|(null)|(null)
C12855|Pisiform_Bone|modify|29-OCT-07|(null)|(null)
C12409|Penis|modify|29-OCT-07|(null)|(null)
C70906|Myringotomy_with_Ear_Tube_Placement|create|29-OCT-07|(null)|(null)
C70907|Central_Institutional_Review_Board|create|29-OCT-07|(null)|(null)
C70908|Esophageal_Dilation|create|29-OCT-07|(null)|(null)
C70909|Mechanical_Ventilation|create|29-OCT-07|(null)|(null)
C70910|Nasogastric_Decompression|create|29-OCT-07|(null)|(null)
C70911|Cardioversion|create|29-OCT-07|(null)|(null)
C70912|Positive_Air_Pressure_Device|create|29-OCT-07|(null)|(null)
C54695|Medical_Product|modify|29-OCT-07|(null)|(null)
C48918|Variance|modify|29-OCT-07|(null)|(null)
C68753|Genomic_Biomarker|modify|29-OCT-07|(null)|(null)
C16622|Genetic_Marker|modify|29-OCT-07|(null)|(null)
C38114|Drug_Route_of_Administration|modify|29-OCT-07|(null)|(null)
C13285|Chromosome_X|modify|29-OCT-07|(null)|(null)
C13286|Chromosome_Y|modify|29-OCT-07|(null)|(null)
C70913|Bioavailability|create|29-OCT-07|(null)|(null)
C70914|Biological_Clearance_Rate|create|29-OCT-07|(null)|(null)
C70915|Elimination_Half_Life|create|29-OCT-07|(null)|(null)
C70916|Half_Life|create|29-OCT-07|(null)|(null)
C70917|Distribution_Volume|create|29-OCT-07|(null)|(null)
C70918|Cmax|create|29-OCT-07|(null)|(null)
C70919|Tmax|create|29-OCT-07|(null)|(null)
C70920|Toxicology_Finding|create|29-OCT-07|(null)|(null)
C70921|ADME_Finding|create|29-OCT-07|(null)|(null)
C70922|Clinical_Chemistry_Finding|create|29-OCT-07|(null)|(null)
C70923|Diagnostic_Efficacy|create|29-OCT-07|(null)|(null)
C70924|Therapeutic_Efficacy|create|29-OCT-07|(null)|(null)
C3824|Lesion|modify|29-OCT-07|(null)|(null)
C60536|Aberrant_Crypt_Focus|modify|29-OCT-07|(null)|(null)
C53301|Acquired_Lesion|modify|29-OCT-07|(null)|(null)
C60643|Adulthood_Lesion|modify|29-OCT-07|(null)|(null)
C66994|Affected_Area|modify|29-OCT-07|(null)|(null)
C43260|Bone_Lesion|modify|29-OCT-07|(null)|(null)
C60644|Childhood_Lesion|modify|29-OCT-07|(null)|(null)
C41457|Circumscribed_Lesion|modify|29-OCT-07|(null)|(null)
C40555|Composite_Lesion|modify|29-OCT-07|(null)|(null)
C53302|Congenital_Lesion|modify|29-OCT-07|(null)|(null)
C41421|Cystic_Lesion|modify|29-OCT-07|(null)|(null)
C51137|Deep_Lesion|modify|29-OCT-07|(null)|(null)
C47826|Diffuse_Lesion|modify|29-OCT-07|(null)|(null)
C54253|Dome-Shaped_Lesion|modify|29-OCT-07|(null)|(null)
C50443|Erosion|modify|29-OCT-07|(null)|(null)
C54201|Exophytic_Papillary_Lesion|modify|29-OCT-07|(null)|(null)
C62108|Extraosseous_Lesion|modify|29-OCT-07|(null)|(null)
C54062|Hereditary_Lesion|modify|29-OCT-07|(null)|(null)
C50597|Iatrogenic_Lesion|modify|29-OCT-07|(null)|(null)
C40559|Intraocular_Lesion|modify|29-OCT-07|(null)|(null)
C62106|Intraosseous_Lesion|modify|29-OCT-07|(null)|(null)
C62226|Juvenile_Lesion|modify|29-OCT-07|(null)|(null)
C48615|Lesion_by_Focality|modify|29-OCT-07|(null)|(null)
C36298|Lesion_by_Grade|modify|29-OCT-07|(null)|(null)
C42078|Lesion_by_Morphology|modify|29-OCT-07|(null)|(null)
C36299|Lesion_by_Stage|modify|29-OCT-07|(null)|(null)
C50632|Lesion_in_Target_Point|modify|29-OCT-07|(null)|(null)
C45965|Lesion_with_Diameter_Greater_than_10mm|modify|29-OCT-07|(null)|(null)
C62450|Lesion_with_Diameter_of_4mm_or_More|modify|29-OCT-07|(null)|(null)
C54003|Lesion_with_Diameter_of_5cm_or_Less|modify|29-OCT-07|(null)|(null)
C41039|Localized_Lesion|modify|29-OCT-07|(null)|(null)
C53415|Locally_Agressive_Lesion|modify|29-OCT-07|(null)|(null)
C43278|Macular_Lesion|modify|29-OCT-07|(null)|(null)
C40557|Metastatic_Lesion|modify|29-OCT-07|(null)|(null)
C36164|Metasynchronous_Lesion|modify|29-OCT-07|(null)|(null)
C41425|Nodular_Lesion|modify|29-OCT-07|(null)|(null)
C53974|Non-Hereditary_Lesion|modify|29-OCT-07|(null)|(null)
C36110|Non-Measurable_Lesion|modify|29-OCT-07|(null)|(null)
C45328|Papulovesicular_Lesion|modify|29-OCT-07|(null)|(null)
C43280|Peau_Chagrine_Lesion|modify|29-OCT-07|(null)|(null)
C35936|Pedunculated_Lesion|modify|29-OCT-07|(null)|(null)
C40560|Polypoid_Lesion|modify|29-OCT-07|(null)|(null)
C40558|Primary_Lesion|modify|29-OCT-07|(null)|(null)
C42094|Rare_Lesion|modify|29-OCT-07|(null)|(null)
C53416|Rarely_Metastasizing_Lesion|modify|29-OCT-07|(null)|(null)
C53303|Rubbery_Skin_Lesion|modify|29-OCT-07|(null)|(null)
C41444|Secondary_Lesion|modify|29-OCT-07|(null)|(null)
C35935|Sessile_Lesion|modify|29-OCT-07|(null)|(null)
C39690|Skin_Papules|modify|29-OCT-07|(null)|(null)
C39623|Skin_Patches|modify|29-OCT-07|(null)|(null)
C53304|Skin_Red_Dot|modify|29-OCT-07|(null)|(null)
C61451|Small_Lesion|modify|29-OCT-07|(null)|(null)
C36109|Superficial_Lesion|modify|29-OCT-07|(null)|(null)
C54621|Synchronous_Lesion|modify|29-OCT-07|(null)|(null)
C16504|Animal_Model|modify|29-OCT-07|(null)|(null)
C41162|Animal_Cancer_Model|modify|29-OCT-07|(null)|(null)
C19833|Dorsal_Skinfold_Window_Chamber_Model|modify|29-OCT-07|(null)|(null)
C17375|Murine_AIDS|modify|29-OCT-07|(null)|(null)
C19261|Non-Mammalian_Organisms_as_Models_for_Cancer|modify|29-OCT-07|(null)|(null)
C19300|Non-Rodent_Model|modify|29-OCT-07|(null)|(null)
C41193|Olfactory_Learning|modify|29-OCT-07|(null)|(null)
C19021|Rodent_Model|modify|29-OCT-07|(null)|(null)
C19272|Transgenic_Model|modify|29-OCT-07|(null)|(null)
C19812|Xenograft_Model|modify|29-OCT-07|(null)|(null)
C70928|Fasting_Status_at_Specimen_Collection|create|29-OCT-07|(null)|(null)
C70929|Comment_on_Clinical_Study_Activity_Relationship|create|29-OCT-07|(null)|(null)
C70930|Comment_on_Test_Result_Reference_Range|create|29-OCT-07|(null)|(null)
C70931|Comment_on_Observation_Result_Relationship|create|29-OCT-07|(null)|(null)
C70932|Laboratory-Generated_Comment|create|29-OCT-07|(null)|(null)
C70933|High_Test_Reference_Range|create|29-OCT-07|(null)|(null)
C70934|Low_Test_Reference_Range|create|29-OCT-07|(null)|(null)
C70935|Test_Reference_Text_List|create|29-OCT-07|(null)|(null)
C70936|Comment_on_Study_Activity|create|29-OCT-07|(null)|(null)
C70937|Cause_or_Rational_for_Missed_Study_Activity|create|29-OCT-07|(null)|(null)
C70938|Mononeuritis_Multiplex|create|29-OCT-07|(null)|(null)
C70939|Randomization_Indicator|create|29-OCT-07|(null)|(null)
C70940|Frequency-Domain_Photon_Migration|create|29-OCT-07|(null)|(null)
C70941|Cotinine|create|29-OCT-07|(null)|(null)
C70942|deCODE_Map|create|29-OCT-07|(null)|(null)
C70943|Marshfield_Linkage_Map|create|29-OCT-07|(null)|(null)
C70944|SLM1_Linkage_Map|create|29-OCT-07|(null)|(null)
C70945|Biospecimen_Collection|create|29-OCT-07|(null)|(null)
C70946|Postal_Address|create|29-OCT-07|(null)|(null)
C67089|PRA-PSM-Expressing_Plasmid|modify|29-OCT-07|(null)|(null)
C70947|Investigator_Signature|create|29-OCT-07|(null)|(null)
C70948|Polo-like_Kinase_1_Inhibitor_GSK461364|create|29-OCT-07|(null)|(null)
C43611|License|modify|29-OCT-07|(null)|(null)
C70949|Investigator_Official_Credentials|create|29-OCT-07|(null)|(null)
C70950|Test_Result_Report|create|29-OCT-07|(null)|(null)
C70951|Description_of_Test_Result|create|29-OCT-07|(null)|(null)
C70952|Numeric_Test_Result|create|29-OCT-07|(null)|(null)
C70953|Hypoxia_Inducible_Factor_1-Alpha_PX-478|create|29-OCT-07|(null)|(null)
C70954|Comment_on_Laboratory_Procedure|create|29-OCT-07|(null)|(null)
C70955|Type_of_Telecommunication_Address|create|29-OCT-07|(null)|(null)
C70956|Comment_on_Observation_Result|create|29-OCT-07|(null)|(null)
C70957|Reason_for_Variance_of_Study_Administrative_Activity|create|29-OCT-07|(null)|(null)
C25678|Signature|modify|29-OCT-07|(null)|(null)
C70958|Subject_Signature_on_Informed_Consent_Form|create|29-OCT-07|(null)|(null)
C67376|International_Unit_per_Liter|modify|29-OCT-07|(null)|(null)
C70959|Submission_Unit_Relationship|create|29-OCT-07|(null)|(null)
C70960|Description_of_Clinical_Study_Activity|create|29-OCT-07|(null)|(null)
C70961|Dose_Description|create|29-OCT-07|(null)|(null)
C70962|Agent_Administration|create|29-OCT-07|(null)|(null)
C70963|Drug_Vehicle_Volume|create|29-OCT-07|(null)|(null)
C70964|Code_System_Version|create|29-OCT-07|(null)|(null)
C70965|Study_Author|create|29-OCT-07|(null)|(null)
C70966|Indicator_of_Authorization_for_Release_of_Confidential_Health_Information|create|29-OCT-07|(null)|(null)
C70967|Indicator_of_Original_Unit_or_Value_of_Reported_Test_Result|create|29-OCT-07|(null)|(null)
C70968|Renal_Cell_Carcinoma_Peptides_Vaccine_IMA901|create|29-OCT-07|(null)|(null)
C70969|Mycobacterium_w|create|29-OCT-07|(null)|(null)
C70970|Type_of_Clinical_Study_Activity_Relationship|create|29-OCT-07|(null)|(null)
C48407|Monoclonal_Antibody_HuAPF31|modify|29-OCT-07|(null)|(null)
C68822|Sodium_Hyaluronate_Topical_Gel|modify|29-OCT-07|(null)|(null)
C42781|Author|modify|29-OCT-07|(null)|(null)
C66737|CDISC_SDTM_Trial_Phase_Terminology|modify|29-OCT-07|(null)|(null)
C25162|Code|modify|29-OCT-07|(null)|(null)
C64208|Concept_Descriptor_Data_Type|modify|29-OCT-07|(null)|(null)
C49100|Data_Value|modify|29-OCT-07|(null)|(null)
C17953|Education_Level|modify|29-OCT-07|(null)|(null)
C16564|Ethnic_Group|modify|29-OCT-07|(null)|(null)
C70971|Vector-peptide_Conjugated_Paclitaxel|create|29-OCT-07|(null)|(null)
C16666|Health_Care_Provider|modify|29-OCT-07|(null)|(null)
C25936|Investigator|modify|29-OCT-07|(null)|(null)
C70972|Type_of_Study_Sponsor|create|29-OCT-07|(null)|(null)
C25294|Test|modify|29-OCT-07|(null)|(null)
C70973|Indicator_of_Displayable_Identifier|create|29-OCT-07|(null)|(null)
C70975|Document_Subtype|create|29-OCT-07|(null)|(null)
C70976|Drug_Vehicle_Unit_of_Volume|create|29-OCT-07|(null)|(null)
C49236|Therapeutic_Procedure|modify|29-OCT-07|(null)|(null)
C49658|Trial_Blinding_Schema|modify|29-OCT-07|(null)|(null)
C15299|Pharmacokinetics|modify|29-OCT-07|(null)|(null)
C70977|Scheduled_Study_Activity_Cause_or_Rational|create|29-OCT-07|(null)|(null)
C70978|phastCon|create|29-OCT-07|(null)|(null)
C68608|Vendor|modify|29-OCT-07|(null)|(null)
C43368|Editor|modify|29-OCT-07|(null)|(null)
C70979|International_HapMap_Project|create|29-OCT-07|(null)|(null)
C67409|Milliinternational_Unit_per_Square_Meter|modify|29-OCT-07|(null)|(null)
C67411|Milliliter_per_Kilogram|modify|29-OCT-07|(null)|(null)
C67412|Milliliter_per_Minute_per_173E10-2_m2_of_Body_Surface_Area|modify|29-OCT-07|(null)|(null)
C67417|Milliliter_per_Minute_per_Millimeters_of_Mercury|modify|29-OCT-07|(null)|(null)
C67418|Milliliter_per_Minute_per_Millimeters_of_Mercury_per_Liter|modify|29-OCT-07|(null)|(null)
C28251|Millimeter|modify|29-OCT-07|(null)|(null)
C48153|Microliter|modify|29-OCT-07|(null)|(null)
C64387|Millimole_per_Liter|modify|29-OCT-07|(null)|(null)
C67423|Millimole_per_Minute_per_Thousand_Pascal_per_Liter|modify|29-OCT-07|(null)|(null)
C48555|Molarity-Based_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C67348|IgM_Phospholipid_Unit|modify|29-OCT-07|(null)|(null)
C41140|Millisecond|modify|29-OCT-07|(null)|(null)
C67428|Million_Units_per_Milliliter|modify|29-OCT-07|(null)|(null)
C67456|Unit_per_Liter|modify|29-OCT-07|(null)|(null)
C67468|Unit_per_Microliter|modify|29-OCT-07|(null)|(null)
C67324|Millivolt|modify|29-OCT-07|(null)|(null)
C67351|Million_Viral_Particles|modify|29-OCT-07|(null)|(null)
C67352|Nanocurie|modify|29-OCT-07|(null)|(null)
C67326|Nanogram_per_Deciliter|modify|29-OCT-07|(null)|(null)
C67429|Nanogram_per_Kilogram|modify|29-OCT-07|(null)|(null)
C67327|Nanogram_per_Liter|modify|29-OCT-07|(null)|(null)
C67329|Source_Data_Not_Available|modify|29-OCT-07|(null)|(null)
C42547|Pascal|modify|29-OCT-07|(null)|(null)
C67264|Plaque_Forming_Unit|modify|29-OCT-07|(null)|(null)
C67331|Picogram_per_Deciliter|modify|29-OCT-07|(null)|(null)
C67434|Picomole_per_Liter|modify|29-OCT-07|(null)|(null)
C67435|Picofarad|modify|29-OCT-07|(null)|(null)
C18064|Rad|modify|29-OCT-07|(null)|(null)
C67436|Retinol_Equivalent|modify|29-OCT-07|(null)|(null)
C67441|RNA_Copies_per_Milliliter|modify|29-OCT-07|(null)|(null)
C42535|Second_Unit_of_Time|modify|29-OCT-07|(null)|(null)
C48508|Micromolar|modify|29-OCT-07|(null)|(null)
C67467|Unit_per_Square_Meter|modify|29-OCT-07|(null)|(null)
C67465|Unit_per_Kilogram|modify|29-OCT-07|(null)|(null)
C67464|Unit_per_24_Hours|modify|29-OCT-07|(null)|(null)
C48524|Patch_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C67446|Radioactive_Seed_Implant_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48548|Troche_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C48537|Spray_Dosing_Unit|modify|29-OCT-07|(null)|(null)
C67476|Picogram_of_Prostaglandin_E2_per_Milligram_of_Protein|modify|29-OCT-07|(null)|(null)
C15446|Adjuvant_Study|modify|29-OCT-07|(null)|(null)
C15788|Clinical_Trials_Diagnosis|merge|29-OCT-07|C15733|Diagnostic_Trial
C15788|Clinical_Trials_Diagnosis|retire|29-OCT-07|(null)|(null)
C15733|Diagnostic_Trial|merge|29-OCT-07|C15733|Diagnostic_Trial
C15733|Diagnostic_Trial|merge|29-OCT-07|C15733|Diagnostic_Trial
C16148|Exclusion_Criteria|merge|29-OCT-07|C25370|Exclusion
C16148|Exclusion_Criteria|retire|29-OCT-07|(null)|(null)
C39496|Preventive_Clinical_Trial|merge|29-OCT-07|C49657|Prevention_Study
C39496|Preventive_Clinical_Trial|retire|29-OCT-07|(null)|(null)
C49657|Prevention_Study|merge|29-OCT-07|C49657|Prevention_Study
C49652|Trial_Indication_Type|merge|29-OCT-07|C49652|Trial_Indication_Type
C49652|Trial_Indication_Type|merge|29-OCT-07|C49652|Trial_Indication_Type
C16471|Costs|retire|29-OCT-07|(null)|(null)
C68436|Triglyceride|retire|29-OCT-07|(null)|(null)
C69101|Gram_per_100_Grams|retire|29-OCT-07|(null)|(null)